,0,1
0,"((5Z)5-(1,3-benzodioxol-5-yl)methylene-2-phenylamino-3,5-dihydro-4H-imidazol-4-one)",1
1,17p13.3,1
2,1-Phosphatidylinositol 3-Kinase,12
3,22q13,1
4,2-Dimensional,1
5,3' Region,1
6,"3,4-Methylenedioxyamphetamine",1
7,3c,1
8,4-dichlorobenzene,1
9,5-bromo-4-chloro-3-indolyl beta-galactoside,1
10,A axonemal microtubule,1
11,A Codes,1
12,AB Term Type,1
13,Abdominal aorta structure,1
14,Aberrant,10
15,ABI1 wt Allele,3
16,Ability,1
17,Ability to Drive,1
18,Ablation,3
19,Abnormal,14
20,Abnormal behavior,1
21,Abnormal degeneration,2
22,Abnormality,1
23,Abnormality of mitochondrial metabolism,1
24,Abnormality of the vasculature,1
25,Absence (morphologic abnormality),18
26,Absolute,1
27,Abstract thinking ability,1
28,Abundance,16
29,Accelerated,2
30,acceptors,1
31,Accident due to exposure to weather conditions,1
32,Accumulation,15
33,Accurate (qualifier),1
34,Acetyltransferase,1
35,acetyltransferase activity,3
36,Acids,1
37,ACP5 gene,1
38,Acquisition (action),2
39,Act Class - investigation,5
40,Act Class - review,2
41,actin cytoskeleton reorganization,1
42,actin filament polymerization,4
43,actin nucleation,1
44,Actin-Binding Protein,1
45,Actins,1
46,Activating PI3K Mutation,1
47,Activation action,124
48,Activation function,1
49,Activator Appliances,1
50,Active Site,1
51,Activities,47
52,activity-dependent neurotrophic factor,1
53,ACTL6A gene,1
54,ACTL6B gene,1
55,"ACTN4 protein, human",1
56,ACTR2 gene,1
57,Acute inflammation,1
58,Acute leukemia,1
59,Acute Undifferentiated Leukemia,3
60,Adaptation,1
61,Adapter Device Component,3
62,Adaptive Thermogenesis,1
63,Adaptor Protein Complex 1,1
64,Adaptor Protein Complex 2,3
65,"adaptor protein complex 2, alpha 2 subunit",1
66,Adaptor Protein Complex beta Subunits,3
67,Adaptor Protein Complex gamma Subunits,5
68,"Adaptor Proteins, Signal Transducing",4
69,Adenocarcinoma of lung (disorder),2
70,Adenosine Triphosphatases,1
71,Adenylate,1
72,Adenylate Cyclase,1
73,ADENYLATE KINASE,2
74,adenylosuccinate,1
75,Adipocytes,4
76,Adjacent,8
77,Administration procedure,1
78,Adrenal Cortex,13
79,ADSL gene,4
80,Adult,56
81,Adulthood,1
82,Advanced phase,1
83,Adverse Event Associated with Vascular,3
84,AF-1 domain binding,1
85,AF-2,2
86,Affecting,8
87,Afferent,1
88,Affinity,11
89,Afibrinogenemia,1
90,Age of Onset,1
91,Age:Time:Point in time:^Patient:Quantitative,1
92,Aggregate,1
93,Aggregation,1
94,Aging,1
95,Agonist,2
96,agonists,2
97,Agreement,1
98,AHSA1 gene,1
99,AK3 gene,2
100,AK4 gene,9
101,AKAP10 gene,4
102,AKAP13 gene,6
103,AKAP13 wt Allele,2
104,AKAP8 gene,1
105,"A-Kinase Anchor Protein 10, Mitochondrial",2
106,AKT Signaling Pathway,1
107,AKT1 gene,10
108,Alanine,3
109,"Albumin Human, USP",1
110,algorithm,1
111,Alkalies,1
112,Alkaline phosphatase stain,1
113,Alleles,8
114,Allogeneic Hematopoietic Stem Cell Transplantation,7
115,Alpha 1,1
116,Alpha 2,1
117,Alpha Granule,1
118,Alpha subunit - qualifier value,3
119,Alpha1 Significance,1
120,Alpha2 Significance,3
121,alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid,3
122,alpha-Lactalbumin,1
123,Alteration,5
124,Alternating,1
125,Alternative,13
126,Alternative Splicing,5
127,Aluminum,1
128,Alzheimer's Disease,3
129,AMBRA1 gene,61
130,Amino Acid Motifs,15
131,Amino Acid Sequence,19
132,Amino Acids,39
133,AMINO ACIDS/PROTEINS,1
134,aminoacid sequence of protein,1
135,Amount type - Differential,3
136,Amount type - Rate,6
137,AMPA Receptors,5
138,"AMPH protein, human",1
139,Amphibians,1
140,Amplification,3
141,Amplitude,2
142,Amyloid,1
143,Amyloid Beta Precursor Protein Measurement,1
144,Amyloid beta-Peptides,1
145,Amyotrophic Lateral Sclerosis,4
146,Anabolism,5
147,Analysis,11
148,analysis aspect,19
149,anatomical layer,9
150,Anatomical maturation,2
151,Anatomical segmentation,4
152,"Anatomy, Regional",3
153,Anchorage,1
154,Anchoring procedure,3
155,Androgen Receptor,1
156,Angiogenic Process,6
157,Angiopoietin-1 Receptor Signaling Pathway,2
158,"Angiopoietin-1 Receptor, Human",2
159,Angiopoietin-2,6
160,Angiopoietins,5
161,Angiotensin II,1
162,"ANGPT1 protein, human",13
163,ANGPT1 wt Allele,1
164,ANGPT2 gene,1
165,ANGPT4 wt Allele,12
166,ANGPTL1 gene,13
167,Animal Model,3
168,Animals,3
169,"Animals, Transgenic",1
170,ANO2 gene,5
171,Anomaly of placenta,1
172,Antagonist muscle action,2
173,Anterior chamber of eye structure,1
174,Anthropological Culture,2
175,Antiapoptotic Agent,1
176,antibiotic G 418,1
177,"Antibodies, in vitro diagnostic",8
178,"Antibodies, Phospho-Specific",1
179,Antigen Presentation,2
180,Antigens,3
181,Anti-inflammatory effect,1
182,Antimicrobial susceptibility,1
183,Antimicrobial Susceptibility Result,1
184,Antineoplastic Agents,1
185,Antioxidant Response Elements,4
186,Antisense Orientation,1
187,Anxiety,1
188,AP1 complex location,2
189,AP1M2 gene,3
190,"APC protein, human",2
191,APH1A gene,4
192,APH1B gene,2
193,Apical Ectodermal Ridge,1
194,Apoptosis,26
195,apparent,4
196,Appearance,1
197,Application Dosing Unit,2
198,AraC Transcription Factor,4
199,Architecture as Topic,1
200,Area,1
201,ARF1 gene,1
202,ARF6 gene,1
203,Arginine,5
204,arginine methyltransferase,1
205,Argininosuccinate,1
206,arginyl-glycyl-aspartic acid,1
207,ARHGEF5 gene,3
208,ARID1B wt Allele,1
209,Arm or Leg Response Group 4,1
210,ARNTL gene,2
211,Array,2
212,Arterial,1
213,Arteries,5
214,As Directed,2
215,ASB2 gene,1
216,Aspartic Acid,1
217,Aspects of congenital malformations,1
218,Assay,2
219,Assembly (construction),10
220,Assessed,3
221,Associate - assistant,15
222,Associate - relationship,4
223,Associated with,40
224,Asthma,1
225,astral microtubule organization,1
226,Asymmetrical synapse,1
227,ATAD1 gene,2
228,Ataxia,2
229,Ataxia Telangiectasia,1
230,"Ataxia, Spinocerebellar",1
231,ATF2 gene,1
232,ATG7 gene,2
233,Atherogenesis,1
234,"Atmosphere, unit of pressure",3
235,Atom (substance),2
236,ATP-dependent chromatin remodeling,1
237,ATR gene,2
238,Attention deficit hyperactivity disorder,3
239,Attenuated by (contextual qualifier),1
240,Atypical,1
241,Auditory recruitment,22
242,Author,1
243,Autism Spectrum Disorders,11
244,Autoimmune Diseases,4
245,autolysosome formation,1
246,Autophagosome,1
247,autophagosome assembly,1
248,Autophagy,40
249,Autophagy-Related Protein 5,1
250,Autophagy-Related Proteins,1
251,Autosomal dominant inheritance,1
252,Auxilins,1
253,Availability of,2
254,Average of Value Derivation Technique,1
255,avoidance,1
256,Awake,1
257,Axial,2
258,Axial skeleton structure,1
259,AXIN2 gene,1
260,Axon,10
261,axon development,1
262,axon growth,1
263,Axon Guidance,1
264,axonal guidance,1
265,Axoneme,2
266,B cell apoptotic process,1
267,B4GALT1 gene,1
268,Background,1
269,Bacterial,1
270,Bacterial Count Measurement,1
271,Baculovirus,1
272,Bad,3
273,Baker's Antifol,3
274,Bands,1
275,Basal,4
276,basal RNA polymerase II transcription machinery binding,1
277,basal transcription machinery binding,1
278,Base Pairing,1
279,Base Sequence,3
280,Baseline,2
281,Basement membrane,1
282,Basic Helix-Loop-Helix Transcription Factors,3
283,Bay-K-8644,1
284,BC-2 protein,1
285,b-cell proliferation,1
286,B-Cell Receptor Complex,1
287,B-Cell Survival Pathway,1
288,BCL2 gene,2
289,"BCR protein, human",3
290,BCYRN1 gene,2
291,Bead Dosage Form,1
292,Beck Lethality Scale,2
293,Beclin-1,6
294,BECN1 gene,4
295,Behavior,4
296,Behavioral Domain,4
297,Beneo Synergy 1,1
298,Best Case Imputation Technique,1
299,beta catenin,7
300,beta1-adrenergic receptor activity,4
301,beta-adrenergic receptor,1
302,beta-catenin binding,1
303,beta-Chemokines,1
304,Beta-defensin 2 Measurement,4
305,"Beta-Galactosidase, human",1
306,beta-Sheet,2
307,BHLHE22 gene,2
308,Bilateral Disease,2
309,Binding (Molecular Function),4
310,Binding action,88
311,Binding Proteins,1
312,Binding Sites,10
313,Biochemical,4
314,Biochemical Activity,1
315,Biochemical Pathway,19
316,Biochemistry,1
317,Bio-Informatics,1
318,biological,8
319,biological adaptation to stress,3
320,Biological Evolution,2
321,Biological Markers,2
322,Biological Models,3
323,Biological Processes,6
324,biological signaling,22
325,Biophysics,2
326,Biopolymer Sequencing,6
327,Biosynthetic Pathways,1
328,"BIRC4 protein, human",7
329,BIRC5 gene,1
330,Birth,1
331,Birth Weight,1
332,bis(2-hydroxybenzylidene)acetone,1
333,Bisulfite Sequencing,1
334,"Blastocyst Implantation, natural",1
335,Blastocyst structure,2
336,Block Dosage Form,1
337,Blockage (obstruction - finding),1
338,Blocking,4
339,blood phenylalanine measurement by Guthrie microbiologic assay,3
340,Blood Platelets,4
341,Blood Pressure,1
342,blood pressure regulation,1
343,Blood Transfusion,1
344,Blood Vessel,5
345,blood vessel morphogenesis,1
346,Blunted,1
347,B-Lymphocytes,10
348,BMP1 gene,1
349,Body growth,1
350,Body structure,2
351,Body Surface Area,2
352,Body temperature measurement,1
353,Body tissue,38
354,Bone Development,1
355,Bone Marrow,1
356,Bone Marrow-Derived Cell,1
357,Bone remodeling,3
358,Bone Resorption,2
359,Bone structure of tibia,1
360,Borg Category-Ratio 10 Perceived Exertion Score 10,1
361,Bos taurus,1
362,Brachyury protein,1
363,BRAHMA,1
364,Brain,48
365,brain development,12
366,brain function,2
367,Brain Gray Matter,1
368,brain size,2
369,brain tissue surgical material,1
370,Brain-Derived Neurotrophic Factor Measurement,4
371,Branched,1
372,Branchial arch structure,1
373,Branching (qualifier value),2
374,BRCA1 gene,2
375,BRD4 gene,49
376,Breast,3
377,Breast Carcinoma,1
378,Breast Feeding,3
379,Brefeldin A,1
380,Bromodeoxyuridine,1
381,Bromodomain,10
382,Bromodomain Containing Protein 2,10
383,brown adipose tissue uncoupling protein,1
384,Brown color,1
385,Brown Fat,4
386,Brucellosis,1
387,BTB-POZ Domain,1
388,BTC gene,4
389,"BTK protein, human",2
390,C17orf96 gene,1
391,C2 Domains,2
392,C7orf49 gene,1
393,C9orf72 gene,12
394,CA3 Term Type,1
395,CACNA1C gene,2
396,CADM1 gene,1
397,Caenorhabditis elegans,4
398,Calcineurin,4
399,Calcineurin B,1
400,Calcium Channel,1
401,calcium channel activity,7
402,Calcium Signaling,1
403,CALM1 wt Allele,1
404,Calmodulin,1
405,calorie unit of energy,11
406,"Calorimeters, Isothermal Titration",1
407,Calvaria,1
408,Calvarial skull defect,1
409,Cancer Biology,1
410,Cancer Pain,1
411,cancer-predisposing genes,1
412,Candidate Disease Gene,2
413,Capacity,4
414,"CAP-Gly Domain-Containing Linker Protein 1, human",10
415,Carboxy-Terminal Amino Acid,5
416,Cardiac - anatomy qualifier,4
417,cardiac development,2
418,Cardiac dysfunction,1
419,Cardiac function,1
420,Cardiac Hypertrophy,7
421,cardiac muscle cell differentiation,1
422,Cardiomyocyte hypertrophy,1
423,Cardiomyopathies,1
424,Cardiovascular,2
425,Cardiovascular Diseases,1
426,Cardiovascular stress testing,2
427,cargo loading into vesicle,1
428,Case (situation),5
429,Casein Kinase II,2
430,CASP14 gene,104
431,CASP8-Associated Protein 2,5
432,caspase,1
433,Catabolism,20
434,Catalytic activity property,1
435,Catalytic Domain,9
436,Cataract,1
437,Cation Exchange Resins,2
438,Caveolae,1
439,caveolin 1,2
440,CBFA2T3 wt Allele,4
441,CCDC88A gene,2
442,"CCL2 protein, human",2
443,CCND1 gene,4
444,CCND2 gene,1
445,CCV gene,1
446,CD300C gene,1
447,CD40 Antigens,1
448,CD40LG wt Allele,3
449,CDC2 Protein Kinase,1
450,cdc42 GTP-Binding Protein,2
451,CDH5 gene,1
452,CDISC Events Class,1
453,CDISC Findings Class,44
454,CDISC Relationship Class,2
455,CDISC SDTM Body Position Terminology,2
456,CDISC SDTM Lesion Complexity Terminology,1
457,CDISC SDTM Subject Status Response Terminology,1
458,CDISC SDTM Submission Domain Abbreviation Terminology,18
459,"CDK2 protein, human",1
460,CDK4/6 Inhibition,1
461,CDK5 gene,4
462,"CDK6 protein, human",8
463,CDK9 gene,1
464,cDNA Library,3
465,CEL gene,11
466,Cell Adhesion,3
467,Cell Adhesion Molecules,6
468,Cell body of neuron,1
469,cell cortex,1
470,Cell Count,1
471,Cell Cycle,1
472,Cell Cycle Arrest,1
473,cell cycle phase transition,1
474,Cell Cycle Progression,1
475,cell cycle regulator,1
476,Cell Death,5
477,Cell Differentiation process,1
478,Cell division,9
479,cell fate,1
480,cell growth,8
481,Cell Invasion,1
482,cell leading edge,1
483,Cell metabolism,1
484,cell motility,4
485,Cell Movement,3
486,Cell Nucleolus,2
487,Cell Nucleus,34
488,Cell of bone,1
489,cell periphery,2
490,Cell physiology,8
491,Cell Polarity,1
492,Cell Proliferation,14
493,Cell Respiration,1
494,Cell secretion,3
495,Cell surface,9
496,Cell Surface Extensions,1
497,Cell Surface Proteins,1
498,Cell Survival,13
499,cell type,11
500,cell-cell adhesion,2
501,Cells,58
502,Cellular,3
503,cellular localization,1
504,Cellular Morphology (discipline),1
505,cellular process,4
506,cellular response to DNA damage stimulus,6
507,cellular response to pH,2
508,cellular targeting,10
509,cellular_component,2
510,CELSR3 gene,1
511,Central Nervous System,18
512,Centric heterochromatin,1
513,centriole replication,1
514,Centromere,1
515,centromere protein F,1
516,Centrosome,11
517,centrosome duplication,1
518,centrosome localization,1
519,"Ceramide Kinase, Human",1
520,Cerebellum,11
521,Cerebral cortex,7
522,Certain (qualifier value),2
523,Cervical atypism,1
524,Cessation of life,7
525,Chain device,1
526,chain of objects,2
527,Chamber of eye,1
528,Changing,24
529,Channel,2
530,channel activity,1
531,Characteristics,4
532,Characterization,18
533,CHD1 gene,28
534,"CHD1 protein, human",1
535,CHD1 wt Allele,2
536,CHD8 gene,10
537,"CHD8 protein, human",4
538,Checkpoint kinase 1,1
539,Chemical Cleavage,3
540,chemical cofactor,1
541,Chemical extraction,1
542,chemosensitization/potentiation,6
543,Chemotactic Factors,1
544,Chicken Meat,2
545,Chimera organism,1
546,Chimeric antigen receptor,2
547,Chinese Hamster Ovary Cell,1
548,Chloride Ion,1
549,Cholinergic Receptors,3
550,Chondrosarcoma,1
551,Choose (action),1
552,Chromaffin Cells,1
553,chromatin immunoprecipitation,5
554,chromatin location,24
555,chromatin remodeling,3
556,Chromatin Remodeling Factor,1
557,chromatin silencing,1
558,Chromatin Structure,5
559,Chromatography,1
560,"Chromatography, Affinity",4
561,"Chromatography, Reverse-Phase",1
562,Chromosomal translocation,1
563,chromosome 11q23,1
564,Chromosome Condensation,2
565,Chromosome Deletion,1
566,chromosome localization,4
567,Chromosome Pairing,1
568,Chromosomes,12
569,"Chromosomes, Artificial, Yeast",1
570,"Chromosomes, Human, Pair 10",1
571,"Chromosomes, Human, Pair 11",2
572,"Chromosomes, Human, Pair 17",1
573,"Chromosomes, Human, Pair 4",1
574,"Chromosomes, Human, Pair 5",1
575,"Chromosomes, Human, Pair 9",1
576,Chronic infectious disease,2
577,Chronic inflammation,1
578,Chronic Kidney Diseases,3
579,Chylomicron retention disease,1
580,Chylomicrons measurement,1
581,Cilia,2
582,Ciliopathies,1
583,cilium assembly,2
584,Circadian Rhythms,1
585,Circulating,1
586,cisplatin/ifosfamide/mesna/mitomycin protocol,2
587,Citric Acid Cycle,2
588,CKAP5 gene,1
589,Clarify,1
590,Class,2
591,Class 1,1
592,Class 2,1
593,Class 5 (qualifier value),1
594,Class III Phosphatidylinositol 3-Kinases,1
595,Classes - encounter,3
596,Classical Lissencephaly,90
597,Classification of information,1
598,Clathrin,3
599,Clathrin Adaptors,2
600,Clathrin-Coated Vesicles,5
601,clathrin-mediated endocytosis,1
602,Clearance,4
603,Clinical act of insertion,1
604,Clinical action,1
605,Clinical presentation,1
606,Clinical Trial Recruitment Plan,5
607,CLIP1 gene,1
608,CLIP2 gene,1
609,CLK3 gene,1
610,Clock Device Component,4
611,CLOCK gene,3
612,Clone Cells,45
613,"Cloning, Molecular",1
614,clustering of voltage-gated calcium channels,1
615,c-myc Genes,6
616,c-myc Proto-Oncogenes,1
617,CNS - Brain - Cerebellum (MMHCC),1
618,CNS - Brain - Hypothalamus (MMHCC),1
619,CNS - Brain (MMHCC),8
620,CNTRL gene,1
621,Coactivated T Cell,2
622,Coat (physical object),2
623,Coating (film),4
624,Cocoa extract,1
625,Coding,4
626,Codon (nucleotide sequence),1
627,"CoFactor brand of 5,10-methylenetetrahydrofolate",3
628,Cognition,2
629,Cognitive,1
630,Cognitive function: initiation,7
631,cohesion,1
632,Coiled-Coil Domain,3
633,Co-Immunoprecipitation,8
634,Colforsin,1
635,Colicin Plasmids,6
636,Collagen fiber,1
637,Collection Object - UML Entity,1
638,Collections (publication),1
639,Collision-Induced Dissociation,6
640,Colon Carcinoma,1
641,colonies (qualifier value),2
642,Colorectal Cancer,2
643,Column (arrangement),1
644,combination of objects,8
645,Combinations (Undergarment),1
646,Communication,1
647,COMP gene,2
648,Compact Pattern,1
649,compactin,1
650,comparative analysis,1
651,comparative study publication,1
652,Comparison,15
653,Compartments [PK],4
654,Compensated,1
655,Compensation as a Defense Mechanism,2
656,competition,2
657,COMPLEMENT COMPONENT C1r/C1s DEFICIENCY,1
658,Complement System Proteins,1
659,Complete,1
660,Complete congenital stationary night blindness,1
661,Complete Pharyngeal Contraction,4
662,Complex,47
663,complex (molecular entity),22
664,Component object,11
665,"Component, LOINC Axis 1",5
666,Composition,4
667,Compound heterozygous,1
668,Comprehensive,4
669,compromise,1
670,Concept Status - Active,10
671,Conditional,5
672,Conditioning (Psychology),1
673,Cone pedicle,1
674,Confirmation,1
675,Confusion,1
676,Congenital Abnormality,11
677,Congenital anomaly of brain,2
678,Congenital Disorders,1
679,Congenital Heart Defects,2
680,Congenital malformation syndrome,1
681,Congenital omphalocele,1
682,conjugation,1
683,Conjunction,3
684,Consequence of,14
685,Consequent,1
686,Conservation,2
687,Consistent with,29
688,constitutive androstane receptor,1
689,Constrain,1
690,Contact with,1
691,contextual factors,3
692,Continuance of life,9
693,Contraction (finding),3
694,Contribution,5
695,control act - action,8
696,control aspects,16
697,Control function,9
698,Conversions,1
699,cooperation,1
700,Coordinate on an axis or a grid,1
701,Core,7
702,Co-Repressor Proteins,2
703,Corneal Neovascularization,1
704,Correlation,4
705,Cortex of bone,1
706,Cortex of Organ,2
707,Cortical actin cytoskeleton,1
708,cortical plate,1
709,COS Cells,5
710,COS-7 Cells,1
711,Cost Control,8
712,Count Dosing Unit,1
713,Couple (action),4
714,Couples (persons),1
715,Covalent Interaction,1
716,CPOX gene,1
717,Cranial,1
718,Cranial sensory ganglion,1
719,craniofacial,2
720,Craniofacial Abnormalities,3
721,craniofacial development,2
722,craniofacial suture morphogenesis,1
723,Crawling,1
724,"Creatine Kinase, MM Form",3
725,"CREBBP protein, human",5
726,"CRK protein, human",1
727,Cross Reactions,1
728,Crossbreeding,8
729,Cross-linking,1
730,Cross-Talk,4
731,CRY1 gene,5
732,Crying,1
733,Cryptochrome-2,12
734,Cryptochromes,1
735,Crystal Structure,5
736,Crystals,1
737,CSPG4 wt Allele,7
738,CTCF gene,3
739,CTNND1 wt Allele,1
740,CTSK gene,1
741,CUL3 gene,10
742,Cullin Family Gene,1
743,cullin-3,5
744,Culture Dose Form,14
745,Cultured Cell Line,9
746,Cultured Cells,1
747,Current (present time),12
748,Customize,1
749,Cutis Laxa,2
750,CX546,1
751,Cyclic AMP-Dependent Protein Kinases,2
752,Cyclin D,6
753,Cyclin E,5
754,Cyclin T1,1
755,Cyclin-Dependent Kinase 4,1
756,Cyclin-Dependent Kinases,2
757,cyclin-dependent protein kinase activity,1
758,Cyclins,1
759,CYFIP1 gene,9
760,CYFIP2 gene,1
761,Cysteine,5
762,Cysteine-Rich Domain,1
763,Cystic Fibrosis,1
764,cystinylglycylglycine,3
765,cytidylyl-3'-5'-guanosine,7
766,Cytochalasin D,1
767,cytokine,3
768,Cytoplasm,11
769,Cytoplasmic,5
770,Cytoplasmic Domain,8
771,cytoplasmic dynein heavy chain,3
772,Cytoplasmic Dyneins,13
773,Cytoplasmic matrix,8
774,Cytoplasmic Protein,2
775,cytoplasmic SCF ubiquitin ligase complex,1
776,cytoplasmic sequestering of protein,1
777,cytoskeletal part,1
778,Cytoskeletal Proteins,3
779,Cytoskeleton,7
780,cytotoxic,1
781,cytotoxicity,1
782,Dab fish,1
783,Daily,1
784,Dancing,1
785,Data call receiving device,57
786,Data Set,1
787,Databases,2
788,day,7
789,Daytime,1
790,"DCN protein, human",1
791,DCX gene,12
792,DDX41 gene,1
793,DDX53 gene,1
794,de novo,2
795,deacetylase activity,1
796,Deacetylation,2
797,debate,1
798,Decidual,1
799,Decipher Prostate Cancer Test,1
800,Declining,1
801,Decrease,14
802,Decreased,1
803,Decreasing,1
804,Deeply,1
805,DEFB1 wt Allele,4
806,defects aspect,37
807,Deficiency,24
808,Deficit,7
809,Definitive,1
810,Definitive endoderm,1
811,Deformity,1
812,Degree Unit of Plane Angle,1
813,Delete - Document Availability Status,1
814,Delta (difference),2
815,demethylation,1
816,Dendrites,5
817,density,3
818,Departure - action,1
819,Dephosphorylation,2
820,Depletion,10
821,Deposition,1
822,Depressed Level of Consciousness,2
823,Deprivation,1
824,Deregulation,2
825,derivatives,1
826,Dermomyotome,1
827,Desert environment,1
828,Designated,6
829,Destination,2
830,Destruction of tissue,1
831,Detached,1
832,Detachment psychological,1
833,Detectable,1
834,Detected (finding),23
835,Detection,3
836,Determination Aspects,3
837,Determination of bacterial growth,1
838,Deubiquitination,1
839,Development,7
840,Development Lot,66
841,Development of the breasts,1
842,Developmental (qualifier value),1
843,Developmental process,1
844,Developmental stages,1
845,Developmental stagnation,2
846,DHX30 gene,1
847,Diabetes Mellitus,7
848,"Diabetes Mellitus, Insulin-Dependent",3
849,diabetic,1
850,Diameter (qualifier value),1
851,Diaphragm Dosage Form,3
852,Diastasis,1
853,dictated - DocumentCompletion,1
854,"Diet, High-Fat",2
855,Different,1
856,Digestion,1
857,Dihydropyridines,1
858,Dimensions,1
859,dimer,3
860,Dimerization,9
861,Diploid Cell,2
862,Diptera,1
863,Direction,2
864,Discharge (release),6
865,discoidin domain receptor 2,1
866,Discriminate,1
867,Disease,10
868,Disease Response,30
869,Disease susceptibility,1
870,disease transmission qualifier,1
871,Disintegration (morphologic abnormality),2
872,Disintegrins,1
873,Disorder of eye,1
874,Dispersion,1
875,disrupted,17
876,Disruption,16
877,Dissecting,1
878,Dissociation,1
879,Distal,2
880,Distribution,1
881,Disturbance,1
882,Diversity,6
883,Divide,2
884,DLG2 gene,4
885,DLG3 gene,1
886,DLG4 wt Allele,4
887,DNA,11
888,dna binding,8
889,DNA Binding Domain,3
890,DNA Breaks,1
891,DNA Damage,3
892,DNA Fragmentation,1
893,DNA glycosylase,1
894,DNA Methylation [PE],2
895,DNA Mutational Analysis,1
896,DNA polymerase activity,1
897,DNA polymerase alpha-primase,1
898,DNA Primase,1
899,DNA primase activity,1
900,DNA Repair,2
901,DNA Replication,9
902,DNA Sequence,19
903,DNA Sequence Rearrangement,1
904,"DNA, Complementary",68
905,"DNA, Double-Stranded",1
906,DNA-Binding Proteins,2
907,DNA-Directed RNA Polymerase,1
908,DNAH7 gene,2
909,DNMT1 gene,7
910,Dock - Manufactured Object,1
911,Document Completion - incomplete,1
912,Document type,1
913,Does carry,1
914,Does steer,1
915,Does turn (finding),1
916,Dominant,5
917,dominant inheritance,1
918,Dominant-Negative Mutation,3
919,Dosage,2
920,Dosing Days to Detection,2
921,Down Syndrome,12
922,Down-Regulation,14
923,Downstream,8
924,DPEP1 gene,8
925,DPEP3 gene,8
926,DPF3 gene,1
927,"Drosophila <fruit fly, genus>",3
928,Drosophila melanogaster,1
929,Drug Delivery Systems,1
930,Drug Design,1
931,Drug-induced,1
932,DRUGS,1
933,Dual,3
934,Dual diagnosis (psychiatry),1
935,Duplicate,3
936,Duplication (finding),5
937,Duration of menstrual flow,1
938,dynactin subunit 1,9
939,Dynamic,1
940,Dynamics,10
941,dynein activity,2
942,Dynein ATPase,18
943,Dynein complex,1
944,dynein heavy chain binding,1
945,DYRK1A gene,42
946,DYRK2 gene,1
947,DYRK3 gene,3
948,DYSFUNCTION - SKIN DISORDERS,1
949,e protein,1
950,E3 SUMO-Protein Ligase PIAS1,1
951,Early,27
952,Early lethal,1
953,Early stage,1
954,E-Box Elements,3
955,E-Cadherin,1
956,Ectoderm,1
957,Ectopic,3
958,Edema,2
959,Edetic Acid,1
960,Effect,25
961,Effective,1
962,Efficacy Study,2
963,Efficiency,3
964,Efficient,5
965,EGF Family of Proteins,1
966,EGF gene,9
967,EGFL6 gene,2
968,"EGFR protein, human",1
969,EGFR wt Allele,2
970,EIF2B5 wt Allele,8
971,elastase activity,1
972,Elastic Fibers,6
973,elasticity,1
974,Electroconvulsive Therapy,1
975,Electron Microscopy,6
976,Electrophoretic Mobility Shift Assay,1
977,Electrophysiology (science),2
978,Elements,1
979,Elevated,5
980,Elevation,1
981,Elicited by,1
982,ELN gene,5
983,ELSPBP1 gene,2
984,Embryo,75
985,EMBRYONAL CELL CARCINOMA,1
986,Embryonic brain,1
987,Embryonic Cell,1
988,Embryonic Development,23
989,Embryonic heart,5
990,Embryonic Lethal Mutation,3
991,Embryonic Nervous System,1
992,Embryonic Stem Cells,12
993,Embryonic tissue,1
994,Emericella nidulans allergenic extract,2
995,emotional dependency,1
996,Encephalomyocarditis virus,1
997,Encode (action),9
998,Encounter due to puberty,1
999,Encounter due to vagabond status,1
1000,End,2
1001,Endocardium Specimen Code,1
1002,Endocervical Route of Drug Administration,1
1003,Endocrine Cells,1
1004,Endocytosis,5
1005,endodeoxyribonuclease III activity,1
1006,Endoderm,4
1007,Endogenous,25
1008,Endopeptidase K,1
1009,Endoplasmic Reticulum,1
1010,Endosomes,1
1011,endothelial cell migration,2
1012,endothelial cell proliferation,2
1013,Endothelial Cells,31
1014,Endothelium,2
1015,energy homeostasis,1
1016,Energy Metabolism,3
1017,Enhance (action),21
1018,Enhancer brand,1
1019,Enhancer of transcription,1
1020,enrich,1
1021,Entity,1
1022,Entity Determiner - specific,2
1023,Entity Name Part Type - family,23
1024,Entry (data),2
1025,"env Gene Products, Human Immunodeficiency Virus",1
1026,Environment,3
1027,Enzymatic Activity [MoA],4
1028,enzyme activity,1
1029,Enzyme Assays,1
1030,Enzyme-Linked Immunosorbent Assay,1
1031,Enzymes,14
1032,"Enzymes, hematological",7
1033,EP300 gene,7
1034,EPHB2 wt Allele,2
1035,Epiblast,1
1036,Epidermal Growth Factor Receptor,1
1037,Epidermal Growth Factor Receptor Pathway Substrate 15,2
1038,Epidermal Growth Factor Receptor Pathway Substrate 8,1
1039,Epidermis,1
1040,Epiphysial cartilage,1
1041,epithelial,2
1042,epithelial cell morphogenesis,1
1043,Epithelial cell of renal tubule,1
1044,Epithelial Cells,10
1045,Epithelial hyperplasia,1
1046,Epithelial proliferation,1
1047,epithelial to mesenchymal transition,1
1048,Epithelioma,1
1049,Epithelium,5
1050,Epitopes,1
1051,Equal,2
1052,Equilibrium,4
1053,Equivalent Weight,1
1054,ErbB Receptors,5
1055,erbB-2 Receptor,3
1056,ERBB3 gene,5
1057,ERBB4 gene,3
1058,ERBB4 Signaling Pathway,3
1059,EREG gene,1
1060,Erg - unit of measure,1
1061,Erythroid,1
1062,Erythroid Cells,1
1063,Erythropoiesis,1
1064,Escherichia coli,6
1065,Essential,24
1066,establishment and maintenance of localization,36
1067,ESTERASE C,3
1068,Estrogen Receptors,1
1069,Estrogens,2
1070,Etiology,4
1071,Euchromatin,2
1072,Eukaryota,2
1073,"Eukaryotic Translation Initiation Factor 4E, human",1
1074,Evaluation,2
1075,Event Consequence - Death,2
1076,Evidence,20
1077,Examined,1
1078,Exception - Property or Attribute,1
1079,Excessive,4
1080,Excitation Contraction Coupling,1
1081,Excitatory Postsynaptic Currents,1
1082,Excitatory Synapse,3
1083,Excretory function,3
1084,Exercise Pain Management,1
1085,Exist,1
1086,EXOC6 gene,1
1087,Exocytosis,1
1088,Exodeoxyribonuclease V,1
1089,Exogenous,4
1090,Exons,14
1091,Expectation,1
1092,expense,2
1093,Experience,1
1094,Experimental Organism Aborted,1
1095,Experimental Result,1
1096,explanation,1
1097,export,1
1098,Exposure to,2
1099,Expressed Sequence Tags,1
1100,Expression procedure,183
1101,expression vector,5
1102,Extent,1
1103,Extracellular,5
1104,Extracellular Domain,9
1105,Extracellular Matrix,2
1106,Extracellular Matrix Degradation,1
1107,Extracellular Matrix Proteins,1
1108,Extracellular Protein,2
1109,Extraction,3
1110,Extraembryonic membranes,1
1111,Extrinsic,4
1112,Eye - Retina (MMHCC),1
1113,FABP4 wt Allele,4
1114,Face,1
1115,Face (spatial concept),2
1116,Facilitation,1
1117,F-Actin,1
1118,Factor,4
1119,failed,3
1120,Failure (biologic function),2
1121,FAK Family Tyrosine Kinase,1
1122,Family,4
1123,Family Dasypodidae,1
1124,Family history of hereditary disease,2
1125,Family member,5
1126,Fanconi anaemia nuclear complex,1
1127,FAS-AS1 gene,1
1128,Fasting,1
1129,Fat-Restricted Diet,1
1130,fatty acid metabolism,1
1131,Fatty Acids,1
1132,FBXL21 gene,2
1133,FBXL3 gene,3
1134,FBXO2 gene,1
1135,Feature,3
1136,feeding of newborn,1
1137,Feeling upset,1
1138,Femto,1
1139,"Fermitin Family Homolog 2, human",4
1140,FERROCHELATASE,1
1141,"Ferrum metallicum, Homeopathic preparation",3
1142,Fertility,4
1143,Fertility Domain,7
1144,Fetal development of the mammalian embryo or fetus,1
1145,FGF1 gene,2
1146,"FGF10 protein, human",1
1147,FGF23 gene,7
1148,"FGF7 protein, human",1
1149,FGFR1 gene,11
1150,"FGFR1 protein, human",31
1151,FGFR1 wt Allele,1
1152,"FGFR2 protein, human",1
1153,"FGFR3 protein, human",1
1154,FGG gene,1
1155,Fibrillins,1
1156,Fibrinogen,2
1157,Fibroblast Growth Factor,43
1158,Fibroblast Growth Factor 2,21
1159,Fibroblast Growth Factor 21 Measurement,7
1160,Fibroblast Growth Factor Receptors,14
1161,fibroblast growth factor-1,1
1162,Fibronectin Type III Domain,4
1163,Fibronectins,2
1164,Fibrosis,1
1165,Fibula,1
1166,Figs - dietary,1
1167,filamentous actin location,1
1168,Filamin C,7
1169,Filamins,6
1170,Firm,1
1171,Flank (surface region),3
1172,Flexible,1
1173,"FLNA protein, human",1
1174,FLNC gene,1
1175,"FLNC protein, human",1
1176,Flow Cytometry,2
1177,Flow Rate,5
1178,FLRT1 gene,1
1179,FLRT2 gene,1
1180,FLRT3 gene,3
1181,Fluorescence,1
1182,Fluorescent in Situ Hybridization,1
1183,Fluorescent stain,1
1184,FMR1 gene,1
1185,"FMR1 protein, human",13
1186,Focal,1
1187,Focal Adhesion Kinase 1,8
1188,Focal Adhesions,6
1189,Folded structure,1
1190,FOLH1 gene,14
1191,Force,1
1192,Forced,1
1193,forebrain development,1
1194,Forkhead Box Protein O4,3
1195,Formation,30
1196,FOS gene,1
1197,Fourier Analysis,1
1198,FOXD3 wt Allele,1
1199,FOXK1 gene,5
1200,FOXO Family,1
1201,FOXP3 gene,6
1202,FOXP3 protein,1
1203,f-protein,1
1204,Fraction of,3
1205,Fragile X Syndrome,1
1206,Fragment of (qualifier value),1
1207,Fragments,2
1208,Frequencies (time pattern),1
1209,Frequently,1
1210,Friedreich Ataxia,17
1211,Frizzled Receptors,1
1212,frontal lobe,1
1213,"FRS2 protein, human",3
1214,Fuhrman Grade 1,2
1215,fully spanning the plasma membrane,2
1216,fumarate,2
1217,Function,30
1218,Functional,39
1219,Functional behavioral assessment,1
1220,Functional Laterality,1
1221,Functional Map,1
1222,Fungal,2
1223,Fused,4
1224,Fusion procedure,3
1225,Fusion protein,2
1226,FXN gene,28
1227,FYN gene,1
1228,FYN wt Allele,1
1229,"FZD2 protein, human",1
1230,G1 to S Transition Process,1
1231,GABA-A Receptor,1
1232,Gamma - unit of measure,9
1233,gamma-Secretase,2
1234,gamma-secretase complex,1
1235,Gamma-Secretase Subunit PEN-2,1
1236,gamma-Tubulin,4
1237,Ganciclovir,1
1238,Gastrointestinal tract structure,3
1239,Gastrulation,5
1240,"GDF15 protein, human",2
1241,Gel,1
1242,Gel Chromatography,3
1243,GenBank,1
1244,Gene Activation,2
1245,Gene Deletion,7
1246,Gene Deletion Abnormality,20
1247,Gene Duplication,1
1248,Gene Enrichment Probability,1
1249,Gene Expression,20
1250,Gene Expression Regulation,2
1251,Gene Feature,1
1252,gene induction,1
1253,Gene Knockdown Techniques,14
1254,Gene Mutation,1
1255,"Gene Products, vif",3
1256,Gene Rearrangement,1
1257,Gene Regulatory Networks,5
1258,Gene Silencing,5
1259,Gene Targeting,4
1260,Generation (action),6
1261,Genes,112
1262,"Genes, Developmental",4
1263,"Genes, Immunoglobulin",1
1264,"Genes, Reporter",8
1265,"Genes, Switch",1
1266,Genetic,2
1267,Genetic Analysis,1
1268,Genetic Hotspot,1
1269,genetic linkage,2
1270,genetic manipulation,1
1271,Genetic Polymorphism,2
1272,Genetic Translation Process,1
1273,Genome,6
1274,Genome Assembly Sequence,1
1275,Genomic DNA,2
1276,Genomic Instability,2
1277,Genomic Library,1
1278,Genomic Stability,2
1279,Genomics,1
1280,genotoxicity,1
1281,Genotype,1
1282,Genus Aria,8
1283,Genus Danio,1
1284,geographic population,4
1285,Geographic state,2
1286,germ cell development,1
1287,Germ Cells,2
1288,germinal center formation,1
1289,Germline,2
1290,Germ-Line Mutation,1
1291,GIT1 gene,1
1292,GLI3 gene,3
1293,Glioblastoma Multiforme,1
1294,Glioma,1
1295,Global,2
1296,Glucocorticoid Receptor,11
1297,glucocorticoid receptor-interacting protein 1,17
1298,Glucocorticoids,4
1299,Glucose,1
1300,Glucose measurement,3
1301,glucose uptake,2
1302,GLUCOSE-6-PHOSPHATASE,3
1303,Glutamate,1
1304,Glutamate Carboxypeptidase II,1
1305,"glutamate carboxypeptidase II, human",1
1306,Glutathione S-Transferase,1
1307,Glutathione S-transferase measurement,1
1308,Glycogen Storage Disease Type I,2
1309,Glycogen storage disease type II,1
1310,glycogen synthase kinase 3 beta,5
1311,Glycogen Synthase Kinases,1
1312,Glycoproteins,1
1313,Golgi Apparatus,4
1314,GOLPH3 gene,1
1315,GOPC gene,1
1316,GOPC wt Allele,1
1317,G-Protein-Coupled Receptors,3
1318,"GPS2 protein, human",4
1319,gram,6
1320,Granulocyte component of blood,1
1321,GRB14 gene,7
1322,GRB2 gene,4
1323,Greek letter alpha (qualifier value),6
1324,Greek letter rho,1
1325,Green Fluorescent Proteins,2
1326,GRIA1 gene,2
1327,GRIA2 gene,2
1328,GRIK1 gene,1
1329,GRIP1 gene,4
1330,GRM6 wt Allele,1
1331,Gross (qualifier value),1
1332,Groups,2
1333,Growth,1
1334,Growth action,8
1335,Growth Cones,1
1336,Growth Factor,7
1337,growth factor receptor-bound protein 10,1
1338,Growth Factor Receptor-Bound Protein 7,7
1339,Growth Factor Receptors,4
1340,growth hormone activity,2
1341,Growth rate,1
1342,Growth retardation,2
1343,GSK1210151A,1
1344,GTF2I gene,25
1345,GTF2IP1 gene,1
1346,GTF2IRD1 gene,6
1347,GTPase-Activating Proteins,1
1348,Guanine Nucleotide Exchange Factors,2
1349,Guanosine Triphosphate,1
1350,Guanosine Triphosphate Phosphohydrolases,5
1351,guidance - Measure Attribute,2
1352,Gut,2
1353,H19 gene,2
1354,Hair follicle structure,1
1355,Half-Life,4
1356,Hamartoma,1
1357,Haploinsufficiency,11
1358,Haplotypes,5
1359,Harmine,1
1360,Has property,6
1361,Having administered,1
1362,"HBEGF protein, human",3
1363,HBEGF wt Allele,2
1364,HCT116 Cells,1
1365,"HDAC1 protein, human",1
1366,HDAC2 gene,1
1367,HDAC9 wt Allele,10
1368,Health,1
1369,Health problem 1,1
1370,Heart,22
1371,Heart- and Neural Crest Derivatives-Expressed Protein 2,1
1372,Heart cell,1
1373,heart development,1
1374,Heart failure,2
1375,heart growth,1
1376,heart morphogenesis,1
1377,Heart tissue,1
1378,Heart Ventricle,1
1379,Heat shock proteins,1
1380,HEK293 Cells,5
1381,HeLa Cells,3
1382,helicase activity,1
1383,Helice,1
1384,Helix-Loop-Helix Motifs,10
1385,Helper-Inducer T-Lymphocyte,1
1386,Hemangioblasts,2
1387,Hemangioma of liver,1
1388,Hematopoiesis,2
1389,Hematopoietic Cell Lineage Pathway,1
1390,Hematopoietic Neoplasms,1
1391,Hematopoietic stem cells,15
1392,Hematopoietic System,1
1393,Heme,2
1394,heme biosynthetic process,2
1395,Hemizygosity,3
1396,Hemoglobin Subunit Beta,1
1397,Hemorrhage,1
1398,Hemostatic function,2
1399,Hep G2 Cells,3
1400,Heparan Sulfate Proteoglycans,4
1401,heparin,7
1402,Hepatic methionine adenosyltransferase deficiency,6
1403,Hepatocyte,2
1404,Hepatocyte Growth Factor,9
1405,Hereditary,3
1406,Hereditary Diseases,3
1407,Heterochromatin,6
1408,heterochromatin-specific nonhistone chromosomal protein HP-1,1
1409,Heterodimerization,1
1410,Heterogeneity,2
1411,Heterogeneous-Nuclear Ribonucleoproteins,1
1412,Heterotrimeric GTP-Binding Proteins,1
1413,Heterozygote,14
1414,HGFAC wt Allele,1
1415,HIF1A gene,1
1416,High,4
1417,High Mobility Group Proteins,1
1418,Highest,1
1419,High-Throughput RNA Sequencing,1
1420,hindbrain,4
1421,Hinge (physical object),1
1422,Hippocampus (Brain),6
1423,Hippocampus hippocampus,10
1424,HIST1H1C gene,4
1425,HIST1H4F gene,4
1426,Histidine,2
1427,Histocompatibility,2
1428,Histologic,1
1429,Histological Techniques,1
1430,Histology aspects,1
1431,Histone antigen,23
1432,Histone Code,2
1433,Histone Deacetylase,5
1434,histone deacetylase 3,1
1435,Histone Deacetylase Complexes,1
1436,Histone deacetylase inhibitor,1
1437,Histone H1,1
1438,Histone H3,2
1439,Histone H3 Lysine 27,2
1440,Histone H3 Lysine 4,4
1441,Histone H3 Lysine 9,1
1442,histone methyltransferase,2
1443,"Histone-Arginine Methyltransferase CARM1, human",20
1444,Histones,2
1445,Histopathologic Grade differentiation,48
1446,Histopathology,2
1447,HIVEP2 gene,4
1448,hiv-infection/aids,1
1449,HMBS gene,1
1450,HMG Domain,1
1451,Homeostasis,5
1452,Homo sapiens,134
1453,homoaconitate hydratase activity,4
1454,Homodimerization,1
1455,Homogenate,1
1456,Homogeneity,1
1457,Homologous Gene,18
1458,Homologous Recombination Pathway,4
1459,Homology (attribute),18
1460,Homology Modeling,1
1461,homopolymer,2
1462,Homozygote,20
1463,Hope (emotion),1
1464,hormonal regulation,1
1465,Hormones,2
1466,Host (organism),2
1467,House mice,1
1468,HP gene,1
1469,HSP90 Heat-Shock Proteins,5
1470,hSWI/SNF,2
1471,human cell line,1
1472,Human cells,3
1473,Human Herpesvirus 5,1
1474,Hybrids,1
1475,Hydrocephalus,1
1476,Hydrophilicity,1
1477,Hydrophobicity,3
1478,Hyperactive behavior,2
1479,Hyperglycemia,1
1480,hypersensitivity desensitization,3
1481,Hypertensive disease,2
1482,Hypertrophy,2
1483,hyphal growth,1
1484,Hypofibrinogenemia,1
1485,Hypomethylation,1
1486,Hypothesis,2
1487,Hypoxia,1
1488,Ideal,1
1489,Identical,6
1490,Identified,46
1491,IFITM3 gene,1
1492,IFNGR2 wt Allele,2
1493,IGA Glomerulonephritis,1
1494,IgE B cell receptor complex,1
1495,IGF2 gene,1
1496,IGFN1 gene,5
1497,IGK gene,1
1498,IL23A wt Allele,1
1499,IL4I1 gene,1
1500,Illness (finding),1
1501,Imbrication (procedure),1
1502,imidazole-4-acetic acid,3
1503,Immature,6
1504,Immortalization,4
1505,Immune response,1
1506,Immune System Finding,1
1507,Immune Tolerance,1
1508,"Immunity, Innate",2
1509,Immunoblotting,1
1510,Immunofluorescence assay,4
1511,Immunofluorescence Microscopy,1
1512,Immunoglobulin C2-set Domain,1
1513,"Immunoglobulin complex location, circulating",4
1514,Immunoglobulin Domains,2
1515,Immunoglobulin E measurement,3
1516,Immunoglobulin G Subclass 1 Measurement,2
1517,Immunoglobulin Isotypes,1
1518,Immunoglobulin-like Domain,7
1519,Immunoglobulins,3
1520,Immunohistochemistry,6
1521,immunologic,1
1522,Immunoprecipitation,15
1523,immunoreactivity,4
1524,Impact food supplement,1
1525,Impacted tooth,1
1526,Impaired,20
1527,Impaired cognition,1
1528,Impaired health,6
1529,Impaired thrombin-induced platelet aggregation,1
1530,Implantation procedure,1
1531,Import into cell,5
1532,Imprinting (Psychology),1
1533,In situ,12
1534,In Situ Hybridization,9
1535,in vitro,65
1536,in vivo,80
1537,inactivation,6
1538,Inactive Healthcare Coverage,1
1539,Inappropriate Specimen,1
1540,Incidence,2
1541,Inclusion,1
1542,Incompetence,1
1543,incorporation,1
1544,Increase,19
1545,Increased,87
1546,Increasing,3
1547,Increment,1
1548,Independently able,1
1549,Indication,1
1550,Indication of (contextual qualifier),1
1551,Individual - insurance coverage level,9
1552,Induce (action),55
1553,Inducer,1
1554,Industrial machine,1
1555,Inefficient,1
1556,"Infant, Newborn",1
1557,Infection,5
1558,Infertility,7
1559,Inflammation,4
1560,Inflammatory cell,1
1561,Influence,10
1562,Information,8
1563,inhibited,19
1564,Inhibition,4
1565,inhibition of growth,1
1566,Inhibitor,10
1567,inhibitors,4
1568,Initiate (source type),1
1569,Injection,1
1570,Injection Route of Drug Administration,1
1571,Inner cell mass,7
1572,Inner Plexiform Layer,3
1573,Insert (object),7
1574,Insulation Device Component,1
1575,Insulitis,4
1576,Intact,10
1577,Integral,1
1578,Integral Membrane Proteins,6
1579,Integration (data processing),1
1580,Integrin alphaVbeta3,6
1581,integrin alphaVbeta5,1
1582,Integrin beta Chains,1
1583,Integrin beta3,6
1584,integrin ligand,1
1585,Integrins,24
1586,Intellectual Disability,5
1587,Intercellular Junctions,2
1588,intercellular transport,1
1589,Interested,2
1590,Interferes with,7
1591,Interferon Gamma Receptor Complex,1
1592,Interferon Type II,20
1593,Interferon-alpha,1
1594,Interleukin-17,1
1595,Interleukin-17A,1
1596,Intermediate Mitosis-Karyorrhexis Index,2
1597,Internal,2
1598,Internal Ribosome Entry Sites,2
1599,internalization,4
1600,Interneurons,1
1601,Interphase Cell,1
1602,Interprets,2
1603,Interventional procedure,3
1604,Intervertebral disc structure,1
1605,Intestine - Small Intestine (MMHCC),1
1606,Intestines,3
1607,"Intestines, Small",1
1608,intracellular protein transport,3
1609,intraciliary transport,1
1610,Intra-embryonic mesoderm,1
1611,Intraocular pressure disorder,2
1612,Intravenous Route of Drug Administration,1
1613,Introduces,1
1614,Introns,5
1615,Invasive Carcinoma,1
1616,Invasiveness,2
1617,Inversion,1
1618,Investigates,23
1619,Investigational,1
1620,Involvement with,5
1621,inward rectifier potassium channel,1
1622,Ion Channel,5
1623,IQGAP1 gene,3
1624,IRF6 wt Allele,1
1625,Iron accumulation in brain,1
1626,iron metabolism,2
1627,"Iron stain method, blood or bone marrow",1
1628,iron-sulfur cluster binding,4
1629,Irregular,1
1630,Islands,1
1631,Isoenzymes,1
1632,Isolate - microorganism,5
1633,Isolated,35
1634,Isolated limb perfusion,1
1635,Isoproterenol,1
1636,ITGA8 gene,1
1637,ITGB3 gene,1
1638,"ITGB3 protein, human",1
1639,ITGB7 gene,1
1640,JUN gene,1
1641,junctophilin,4
1642,JUND gene,4
1643,juxtamembrane,1
1644,juxtaparanode region of axon,4
1645,KAT2B gene,1
1646,KCNA2 gene,3
1647,KCNJ4 gene,7
1648,KDR gene,1
1649,KEAP1 gene,31
1650,KELL NULL,5
1651,Ketamine,2
1652,KIAA0319 gene,33
1653,Kidney,10
1654,Kidney Neoplasm,1
1655,Killer-Cell Immunoglobulin-Like Receptor,1
1656,kinase activity,6
1657,kinase inhibitor,2
1658,Kind of quantity - Shape,1
1659,Kinesin,1
1660,Kinetics,1
1661,Kinetics (discipline),4
1662,Kinetochores,3
1663,KITLG gene,1
1664,KL wt Allele,6
1665,"KLB protein, human",5
1666,KMT2A gene,5
1667,Knock-in,2
1668,Knock-out,3
1669,KNOWLEDGE (recall and interpretation ability),1
1670,KNTC1 gene,1
1671,Kringles,1
1672,KY gene,7
1673,Labeled (qualifier),2
1674,Labeling Activity,1
1675,Labels (device),1
1676,Laboratory,1
1677,Lacking,3
1678,LacZ Genes,6
1679,Landscapes,2
1680,LAT2 gene,1
1681,late pregnancy,1
1682,Latent,1
1683,"LDLR protein, human",4
1684,Lead compound,1
1685,Learning,11
1686,Length,4
1687,Leptomeninges,1
1688,Lesion,1
1689,Lethal,5
1690,Leucine,3
1691,Leucine-Rich Repeat,2
1692,leukemia,2
1693,"Leukemia, Myelocytic, Acute",5
1694,leukocyte homeostasis,1
1695,Leukotriene D4 Measurement,7
1696,Levels (qualifier value),72
1697,LGALS4 gene,1
1698,Libraries,4
1699,life span,1
1700,Ligand Binding,6
1701,Ligand Binding Domain,7
1702,Ligands,22
1703,Limb Buds,2
1704,Limb structure,2
1705,Limited (extensiveness),1
1706,LIN7C gene,1
1707,Linear,1
1708,Linked gene,1
1709,lipid kinase activity,1
1710,lipid mediator,1
1711,Lipid R1 MRI,2
1712,Lipopolysaccharides,1
1713,LIS1 Pathway,2
1714,Lissencephaly,18
1715,Lissencephaly 3,1
1716,LISSENCEPHALY 4,1
1717,Listeria monocytogenes,1
1718,Lithium,1
1719,Liver carcinoma,1
1720,Liver Flavor,7
1721,Liver parenchyma,1
1722,Local,1
1723,local level,1
1724,localization,1
1725,localization within membrane,1
1726,Localized,37
1727,location participation type,4
1728,Locus,4
1729,Locus Control Region,1
1730,Logical Condition,4
1731,Long,6
1732,Long-term,11
1733,Long-Term Depression Pathway,4
1734,Long-Term Potentiation Pathway,8
1735,Looping Medical Device Problem,1
1736,Loss,28
1737,Lost Medical Device,1
1738,Lower (action),3
1739,Lower case Roman letter b,1
1740,LRFN1 gene,4
1741,LRFN2 gene,3
1742,LRFN3 gene,2
1743,LRFN4 gene,3
1744,LRFN5 gene,2
1745,LRIT3 gene,7
1746,LRP8 gene,5
1747,L-Type Calcium Channels,1
1748,luciferin monooxygenase activity,3
1749,Lung,6
1750,LY 294002,1
1751,Lyase Gene,1
1752,lymph node development,1
1753,Lymphocyte Activation,1
1754,Lymphocytic (qualifier value),1
1755,"Lymphohistiocytosis, Hemophagocytic",1
1756,Lysine,4
1757,lysophosphatidic acid,1
1758,Lysosomes,1
1759,Macromolecular alteration,2
1760,macrophage,10
1761,Macrophage Activation,1
1762,Macrophage Colony-Stimulating Factor,3
1763,"Macrophages, Peritoneal",1
1764,Made redundant (finding),1
1765,Madin Darby Canine Kidney Cells,5
1766,MAGEE1 gene,1
1767,Main,5
1768,main terminal branch,1
1769,Maintenance,13
1770,Male Phenotype,14
1771,"Malformations of Cortical Development, Group II",5
1772,Malignant neoplasm of breast,3
1773,Malignant Neoplasms,15
1774,Mammalian Cell,14
1775,Mammals,55
1776,Mammary Epithelium,6
1777,Mammary gland,5
1778,mammary gland development,2
1779,MAMSTR gene,2
1780,manchette,1
1781,Manifest,1
1782,Manifestation of,1
1783,Manipulation procedure,1
1784,MAP Kinase Cascade,1
1785,"MAPK14 protein, human",1
1786,MAPK8IP1 gene,1
1787,mapped,7
1788,Mapping (action),5
1789,Marginal Zone,2
1790,Marines,1
1791,MARK2 gene,2
1792,Markers (device),7
1793,Mass Spectrometry,6
1794,Massive,2
1795,Massively-Parallel Sequencing,1
1796,Mass-to-Charge Ratio,1
1797,mast cell,3
1798,Mathematical Factor,4
1799,Mathematical Model,1
1800,Mathematical Operator,77
1801,matrigel,1
1802,Matrix Attachment Regions,2
1803,Matrix Metalloproteinase 9,1
1804,Mature,21
1805,MBD2 gene,14
1806,MBD3 gene,15
1807,MBD4 gene,1
1808,"MBD4 protein, human",8
1809,MCF-7 Cells,1
1810,"MCM4 protein, human",1
1811,MDF Attribute Type - Indicator,1
1812,MDM2 gene,1
1813,Measured Tumor Identification,1
1814,Measurement,4
1815,Mechanism (attribute),56
1816,MECOM gene,4
1817,MECP2 gene,1
1818,MECP2 wt Allele,4
1819,Mediate,1
1820,Mediator brand of benfluorex hydrochloride,1
1821,Mediator of activation protein,5
1822,Medical Device Misassembled by Users,1
1823,Medical Product Stability,5
1824,Medium,1
1825,MEF2 Transcription Factors,15
1826,MEF2A gene,4
1827,MEF2C gene,8
1828,MEF2D gene,1
1829,MEFV gene,1
1830,Megakaryocytes,3
1831,Megakaryocytopoiesis,1
1832,meiotic cell cycle,4
1833,Meiotic chromosome,2
1834,Meiotic Prophase I,2
1835,Meiotic Recombination,1
1836,Melanosomes,1
1837,member,47
1838,Membrane,5
1839,membrane budding,1
1840,Membrane Proteins,3
1841,Membrane Transport Proteins,2
1842,membrane-associated guanylate kinase,5
1843,memory b cell,3
1844,Memory Device Component,13
1845,Memory impairment,1
1846,Memory performance,1
1847,Memory recall,1
1848,Mental association,31
1849,Mental concentration,8
1850,Mental Depression,3
1851,Mental disorders,1
1852,Mental Orientation,3
1853,Mental Retardation,3
1854,mercaptopurine,1
1855,Mesenchyma,1
1856,Mesoderm,7
1857,mesodermal,4
1858,Mesodermal cell,2
1859,messenger ribonucleoprotein,2
1860,Mesylates,1
1861,"MET protein, human",1
1862,MET wt Allele,3
1863,Metabolic,1
1864,Metabolic Inhibition,36
1865,metabolic rates,1
1866,Metabolism,1
1867,Metalloproteases,1
1868,Metazoa,1
1869,Methionine,1
1870,Methodology,1
1871,Methods,1
1872,Methyl Methanesulfonate,1
1873,methylate,6
1874,Methylation,20
1875,methyl-CpG binding,1
1876,Methyltransferase,2
1877,methyltransferase activity,1
1878,MG 132,1
1879,Mi-2 Nucleosome Remodeling and Deacetylase Complex,1
1880,MICALL2 gene,4
1881,"Mice, Inbred NOD",2
1882,"Mice, Knockout",7
1883,"Mice, Transgenic",7
1884,Microarray,1
1885,Microarray Analysis,3
1886,Microcephaly,2
1887,Micrococcal Nuclease,1
1888,Microfibrils,1
1889,Microfilaments,9
1890,Microglia,1
1891,Microinjections,5
1892,"Microscopy, Confocal",2
1893,"Microscopy, Immunoelectron",1
1894,Microtubule cytoskeleton,1
1895,Microtubule-Associated Proteins,2
1896,Microtubule-Associated Proteins 1A/1B Light Chain 3,1
1897,Microtubule-Organizing Center,2
1898,Microtubules,40
1899,Midbrain structure,3
1900,Midline 1 RING Finger Protein,1
1901,migrated,8
1902,"Migration, Cell",6
1903,Migratory (qualifier value),2
1904,Miller Dieker syndrome,12
1905,Minichromosome Maintenance 1 Protein,2
1906,Minichromosome Maintenance Complex Component 5,1
1907,Missense Mutation,2
1908,Missing Study Animal,2
1909,Mitochondria,21
1910,Mitochondrial Biogenesis,1
1911,Mitochondrial Degradation,3
1912,mitochondrial depolarization,2
1913,Mitochondrial Diseases,1
1914,mitochondrial DNA metabolic process,1
1915,Mitochondrial Inheritance,13
1916,Mitochondrial matrix,2
1917,"Mitochondrial Membrane, Outer",2
1918,Mitochondrial Membranes,2
1919,mitochondrial processing peptidase,1
1920,Mitochondrial Proteins,2
1921,Mitogen-activated protein,8
1922,mitogen-activated protein kinase p38,2
1923,Mitogen-Activated Protein Kinases,4
1924,mitogenic activity,2
1925,Mitosis,10
1926,Mitotic,1
1927,Mitotic Cell Cycle,5
1928,Mitotic chromosome,7
1929,Mitotic Spindle Apparatus,1
1930,Mixed phenotype acute leukemia,4
1931,Mixture,1
1932,"MLL protein, human",7
1933,MLL/MLLT3 Fusion Gene,1
1934,mmHg,1
1935,MMP9 gene,1
1936,Model,2
1937,Model Number,7
1938,"Models, Genetic",1
1939,"Models, Molecular",1
1940,Moderation,1
1941,Modified By,2
1942,Modulated,28
1943,Module,2
1944,Molecular,2
1945,MOLECULAR BASIS,6
1946,Molecular Conformation,1
1947,Molecular helix,2
1948,Molecular Mass,2
1949,Molecular Target,2
1950,Molecular Weight,3
1951,Molecule,21
1952,Monkeys,1
1953,Monobasic Proteolytic Cleavage Site,1
1954,Monoclonal Antibodies,1
1955,monomer,2
1956,Monomeric GTP-Binding Proteins,2
1957,Monophasic,1
1958,Morphogenesis,4
1959,morphogenesis of a branching structure,1
1960,Morphologic Complete Response,1
1961,morphological,2
1962,"Mortality, Premature",1
1963,Mother (person),4
1964,Motility result,2
1965,motor movement,2
1966,Motor protein,1
1967,Mount used,1
1968,Mouse Cornea,1
1969,Mouse Embryonic Stem Cells,7
1970,Mouse Heart,3
1971,Mouse Liver,1
1972,Mouse mammary tumor virus,1
1973,Mouse Model,4
1974,Mouse Ovary,1
1975,Mouse Prostate Gland,1
1976,Mouse Protein,1
1977,Mouse Skin,1
1978,Mouse Strains,1
1979,Mouse Testis,3
1980,Movement,3
1981,MPP4 gene,1
1982,mRNA synthesis,1
1983,MTA1 gene,2
1984,MTOR gene,8
1985,MTX1 gene,8
1986,MTX2 gene,13
1987,MUC20 gene,6
1988,Multigene Family,1
1989,Multiple Sclerosis,1
1990,Multiprotein Complexes,1
1991,Muridae,1
1992,Murine,41
1993,Mus,88
1994,Muscle,9
1995,muscle cell differentiation,4
1996,Muscle Cells,9
1997,Muscle Development,2
1998,Muscle Fibers,4
1999,Muscle function,1
2000,"Muscle, Smooth, Vascular",2
2001,"Muscle, Striated",2
2002,"Muscular Dystrophies, Limb-Girdle",1
2003,Muscular Dystrophy,2
2004,"MUSK protein, human",4
2005,Mutagenesis Process,1
2006,mutant,55
2007,Mutant Proteins,4
2008,Mutation,48
2009,Mutation Abnormality,33
2010,mutation analysis,1
2011,MYC Family Protein,1
2012,Mycobacterium avium infection,2
2013,Mycobacterium Infections,1
2014,MYEF2 gene,5
2015,Myelin Sheath,1
2016,MYL4 gene,5
2017,Myoblasts,8
2018,Myocardial degeneration,2
2019,Myocardial Infarction,1
2020,Myocardium,3
2021,MYOCD gene,4
2022,myocyte enhancer factor 2C,1
2023,"Myocytes, Cardiac",26
2024,"Myocytes, Smooth Muscle",5
2025,MYOD1 gene,8
2026,Myofilaments,1
2027,Myogenesis,3
2028,Myogenin,2
2029,Myopathy,1
2030,myosin-binding protein C,1
2031,"N,N-dimethylarginine",1
2032,Na(+)/H(+) Exchange Regulatory Cofactor NHE-RF3,1
2033,Name Given at Birth,3
2034,National reporting jurisdiction:Loc:Pt:^Event:Nom,2
2035,Native (qualifier value),3
2036,Natural Killer Cells,1
2037,NCF1 gene,3
2038,NCI Thesaurus Property,1
2039,NCKAP1 gene,5
2040,NCOA1 gene,13
2041,"NCOA1 protein, human",2
2042,NCOA2 gene,43
2043,NCSTN gene,5
2044,NDE1 gene,6
2045,NDEL1 gene,36
2046,NDFIP1 gene,2
2047,Neck,1
2048,Negative,10
2049,Negative Charge,1
2050,negative regulation of excitatory postsynaptic potential,1
2051,Negative Regulation of G2 to M Transition,2
2052,NEIL2 gene,1
2053,Neocortex,3
2054,Neonatal (qualifier value),5
2055,Neoplasms,1
2056,Neoplastic Cell Transformation,5
2057,Nerve Degeneration,3
2058,Nerve Growth Factor,3
2059,nerve supply,1
2060,Nerve Tissue,2
2061,nervous system disorder,2
2062,Nervous system structure,1
2063,nestin protein,1
2064,Network,8
2065,neural,2
2066,Neural Crest,2
2067,neural crest cell migration,2
2068,Neural Crest Cells,3
2069,Neural Network Simulation,1
2070,Neural Plate,1
2071,Neural Stem Cells,5
2072,Neural tube,2
2073,neural tube closure,1
2074,Neural Tube Defects,1
2075,Neuregulin Receptor,1
2076,Neuregulins,6
2077,Neurites,5
2078,Neuroblast,2
2079,neurocognitive,1
2080,NEUROD2 gene,3
2081,Neurodegenerative Disorders,4
2082,neurodevelopment,1
2083,Neuroepithelial,1
2084,Neuroepithelium,3
2085,Neurofibrillary degeneration (morphologic abnormality),1
2086,Neurogenesis,9
2087,Neuroglia,11
2088,Neurologic (qualifier value),1
2089,Neurologic Deficits,1
2090,Neurological observations,6
2091,neuron component,1
2092,neuron development,7
2093,neuron differentiation,2
2094,neuron migration,2
2095,neuron structure,1
2096,neuronal,5
2097,Neuronal Differentiation,3
2098,Neuronal Outgrowth,2
2099,Neuronal Plasticity,4
2100,neuronal signal transduction,1
2101,Neurons,53
2102,Neuropathology,1
2103,Neuropeptides,1
2104,Neuroprotection,1
2105,Neuroprotective Effect,2
2106,Neurosecretory Systems,1
2107,Neurotransmitter Receptor,2
2108,neurotransmitter release,1
2109,Neurulation,1
2110,neutrophil,3
2111,Never (frequency),1
2112,New,9
2113,NFE2L2 gene,1
2114,NFE2L2 wt Allele,25
2115,NFI Transcription Factors,2
2116,NF-kappa B,1
2117,NFS1 gene,1
2118,"Night blindness, congenital stationary",1
2119,Night time,1
2120,Ninein,1
2121,Nisoldipine,2
2122,Nitric Oxide Synthase,1
2123,nitric-oxide synthase inhibitor activity,2
2124,N-Methylaspartate,1
2125,N-Methyl-D-Aspartate Receptors,7
2126,No effect,1
2127,No incoordination,1
2128,No reaction,1
2129,No structural defects,1
2130,Nocodazole,1
2131,Non-Clinical Postnatal Trial Phase,6
2132,Nongranular leukocyte,1
2133,"Normal, Unit of Concentration",10
2134,North,1
2135,Northern Blot,1
2136,Northern Blotting,12
2137,"NOS3 protein, human",3
2138,"NOTCH1 protein, human",1
2139,Nothing,1
2140,"NR3C2 protein, human",1
2141,NR4A2 gene,1
2142,NR4A3 gene,1
2143,"NRBP protein, human",1
2144,NRG1 gene,1
2145,"NRG1 protein, human",3
2146,NTHL1 wt Allele,1
2147,NUAK1 wt Allele,3
2148,nuclear,4
2149,Nuclear accumulation,1
2150,Nuclear Export Signals,2
2151,nuclear hormone receptor activity,1
2152,Nuclear Hormone Receptors,1
2153,Nuclear Lamina,1
2154,Nuclear LIM Interactor-Interacting Factor 2,2
2155,Nuclear Localization Signals,1
2156,Nuclear Magnetic Resonance,1
2157,nuclear migration,2
2158,nuclear periphery,1
2159,nuclear pore distribution,2
2160,nuclear pore localization,7
2161,Nuclear Proteins,4
2162,Nuclear Receptor Coactivators,1
2163,"Nuclear Receptor Subfamily 1, Group F, Member 1",1
2164,"nuclear receptor subfamily 1, group H, member 3",1
2165,"Nuclear Receptor Subfamily 4, Group A, Member 1",1
2166,Nuclear Translocation,1
2167,nucleic acid biosynthesis,1
2168,nucleocytoplasmic transport,1
2169,Nucleosomes,1
2170,Nucleotides,4
2171,Null Allele,5
2172,Null Value,1
2173,Numb (emotional response),1
2174,Numbers,2
2175,"Numerical Analysis, Computer-Assisted",1
2176,Numerous,4
2177,Nutrients,3
2178,NYAP1 gene,1
2179,NYAP2 gene,1
2180,O(6)-Methylguanine-DNA Methyltransferase,1
2181,Obesity Adverse Event,6
2182,Object Attribute,1
2183,objective (goal),1
2184,Observation - diagnostic procedure,3
2185,Observation in research,10
2186,Observation parameter,3
2187,Observed,3
2188,Obstetric Delivery,4
2189,Obstructed,1
2190,Obstruction,6
2191,Off,1
2192,Olfactory Neuroblastoma,1
2193,Olfactory Pathways,1
2194,Oligodendroglia,2
2195,Oligodeoxyribonucleotides,2
2196,Oligonucleotide Primers,1
2197,Oligonucleotide Synthesis,1
2198,Oligonucleotides,1
2199,Oncogene ETS,1
2200,Oncogene MAX,1
2201,Oncogenes,2
2202,Oocytes,2
2203,Open,2
2204,Open Reading Frames,14
2205,Operator gene,1
2206,"Opitz GBBB Syndrome, X-Linked",1
2207,Opposite,2
2208,Optimization,1
2209,Options,1
2210,orders - HL7PublishingDomain,1
2211,Organ,6
2212,Organelles,2
2213,Organism,3
2214,Organized,6
2215,Organogenesis,2
2216,Orofaciodigital syndrome 9,4
2217,Orphan Nuclear Receptor ROR-gammaT,7
2218,Orthologous Gene,1
2219,Oscillator Device Component,3
2220,osteoblast differentiation,1
2221,Osteoblasts,2
2222,osteoclast differentiation,3
2223,Osteoclastogenesis,3
2224,Osteoclasts,7
2225,Osteofibrous Dysplasia,4
2226,Osteogenesis,2
2227,Osteoplasty,1
2228,Other Toxicity Studies: Dependence,2
2229,outer membrane,2
2230,Outlines (document),1
2231,Outpatient Physical Therapy Improvement in Movement and Assessment Log (OPTIMAL) Survey,1
2232,Overlap,1
2233,Oxidants,1
2234,Oxidative,2
2235,Oxidative Stress,2
2236,Packing (action),1
2237,Packing Dosage Form,1
2238,PAF1 gene,3
2239,PAFAH1B1 gene,18
2240,PAFAH1B1 wt Allele,4
2241,PAFAH1B2 gene,1
2242,PAFAH1B3 gene,1
2243,PAFAH2 gene,4
2244,Page (document),1
2245,Paint,1
2246,PAK2 gene,6
2247,PAK2 kinase,3
2248,Pakistan,5
2249,Palmitoylation,1
2250,Paracrine Communication,1
2251,Paralogous Gene,1
2252,paranodal junction,1
2253,Paraxial Mesoderm,1
2254,PARK2 gene,10
2255,Parkinson Disease,1
2256,Partial,2
2257,Participant,2
2258,participation,3
2259,Participation Type - origin,2
2260,Particle,1
2261,Partner in relationship,4
2262,"PASD1 protein, human",4
2263,Pathogenesis,3
2264,Pathogenic,1
2265,Pathogenic organism,1
2266,Pathologic,6
2267,Pathologic Complete Response,6
2268,Pathologic Neovascularization,3
2269,Pathological aspects,2
2270,Patient Care Bundles,1
2271,Patients,24
2272,PATJ gene,2
2273,Patterns,21
2274,PAWR gene,2
2275,PCDHB11 gene,3
2276,PCNT gene,4
2277,PD 98059,2
2278,"PDK1 protein, human",1
2279,PDLIM5 gene,1
2280,PDZ Domains,1
2281,Peak level,2
2282,peptidase activity,1
2283,Peptide Elongation Factor 1,2
2284,Peptide Hydrolases,1
2285,Peptide Initiation Factors,2
2286,Peptides,1
2287,PER2 gene,1
2288,PER3 gene,1
2289,Pericentriolar Material 1 Protein,2
2290,perinuclear endoplasmic reticulum,1
2291,Period (temporal qualifier),5
2292,periodate-oxidized adenosine,1
2293,Periodicity,6
2294,Periosteal Route of Administration,1
2295,Periosteum,2
2296,Peripheral,1
2297,peripheral membrane protein 43K,1
2298,Persistent,1
2299,Persons,1
2300,Pervasive Development Disorder,1
2301,Pharmacokinetics: Distribution,13
2302,Pharmacokinetics: Metabolism,4
2303,pharmacological,6
2304,Pharmacology,1
2305,pharyngeal development,1
2306,Pharyngeal pouch,1
2307,Pharyngeal Stripping Wave Absent,3
2308,Pharyngeal structure,2
2309,Phase,4
2310,Phase 2,1
2311,Phase 3 Clinical Trials,1
2312,Phenotype,13
2313,Phenotypic abnormality,1
2314,Phenylephrine,1
2315,PHF10 gene,1
2316,Phorbol,1
2317,Phorbol Esters,1
2318,Phosphatidate Phosphatase,2
2319,phosphatidylinositol 3-kinase binding,1
2320,Phosphatidylinositol 3-Kinases,1
2321,"Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatase 1",5
2322,phosphatidylinositol-3-phosphate binding,1
2323,Phosphatidylinositols,5
2324,Phospholipase,1
2325,Phospholipase C,2
2326,Phospholipase C gamma,4
2327,Phospholipids,1
2328,Phosphopeptides,10
2329,Phosphoproteins,3
2330,phosphoric monoester hydrolase activity,1
2331,Phosphoric Monoester Hydrolases,3
2332,Phosphorylation,140
2333,Phosphorylation Site,1
2334,Phosphoserine,1
2335,Phosphotransferases,10
2336,Phosphotyrosine,4
2337,phosphotyrosine binding,7
2338,Phosphotyrosine Binding Domain,2
2339,photoreceptor disc membrane,1
2340,Photoreceptors,2
2341,Physical,1
2342,Physical Examination,2
2343,Physical shape,5
2344,Physiologic Coordination,2
2345,Physiologic hypertrophy,2
2346,Physiologic Organization,11
2347,Physiological,12
2348,physiological aspects,5
2349,Physiological Processes,3
2350,Pick Disease of the Brain,3
2351,Picture,1
2352,PIK3C3 wt Allele,1
2353,"PIM1 protein, human",1
2354,PINK1 gene,1
2355,Pituitary Gland,5
2356,Pituitary hormone preparation,2
2357,PKN2 gene,5
2358,PLA2G1B gene,1
2359,"PLA2G7 protein, human",5
2360,Placement action,1
2361,Placenta,3
2362,Plasma,1
2363,Plasma Cells,1
2364,Plasma membrane,11
2365,Plasmids,3
2366,Plasticity,7
2367,Platelet Activating Factor,22
2368,Platelet Activation,2
2369,Platelet aggregation measurement,1
2370,Platelet Count measurement,2
2371,Platelet Glycoprotein GPIIb-IIIa Complex,2
2372,Platelet Membrane Glycoprotein IIb,1
2373,Platelet Size,1
2374,Platelet-Activating Factor Acetylhydrolase IB Subunit Alpha,1
2375,Platelet-Derived Growth Factor,1
2376,Pleckstrin Homology Domains,16
2377,PLEK gene,1
2378,Pliability,2
2379,Plication,1
2380,PLK1 gene,1
2381,PLK3 gene,6
2382,Pluripotent,3
2383,Pluripotent Stem Cells,1
2384,"Pneumonia, Interstitial",1
2385,Point Mutation,1
2386,Polyadenylation,1
2387,Polyclonal antibody,1
2388,Polycomb,4
2389,Polymerase Chain Reaction,3
2390,Polymerization,3
2391,Polymers,2
2392,Polymorphism,1
2393,Polynucleotides,1
2394,Polypeptides,3
2395,Polypyrimidine Tract-Binding Protein 3,1
2396,Polyubiquitination,6
2397,Population Group,4
2398,population migration,27
2399,PORPHOBILINOGEN SYNTHASE,1
2400,Positioning - therapy,2
2401,Positioning Attribute,2
2402,Positive Charge,6
2403,Positive Transcriptional Elongation Factor B,9
2404,post-Golgi vesicle-mediated transport,1
2405,Postmortem period,1
2406,Postpartum Period,2
2407,Post-Synaptic Density,22
2408,postsynaptic density proteins,1
2409,Postsynaptic Membrane,4
2410,Post-Translational Protein Processing,4
2411,Potassium Ion,1
2412,potential,7
2413,PPARGC1A gene,3
2414,PPAT gene,1
2415,PPIA gene,6
2416,PPIase activity,3
2417,PPP1R13B wt Allele,3
2418,PPP2R4 gene,2
2419,PPP3CA gene,1
2420,PPP3CB gene,1
2421,PRB2 gene,1
2422,PRDM16 gene,4
2423,Precocious,1
2424,Precursor,1
2425,prediction,4
2426,Predominate,1
2427,Pregnancy,1
2428,Premature aging syndrome,1
2429,prerequisite,1
2430,Presenilins,2
2431,presynaptic density protein 95,18
2432,presynaptic grid,3
2433,pre-synaptic ribbon,1
2434,Presynaptic Terminals,1
2435,Prevalence aspects,1
2436,Preventing (action),5
2437,Primary,4
2438,Primary Cell Culture,2
2439,Primary congenital glaucoma,5
2440,Priming,1
2441,Primitive,2
2442,Primitive Streak,2
2443,Privacy Level - Isolation,7
2444,PRL gene,2
2445,PRMT1 gene,1
2446,Probability Distribution Type - beta,4
2447,ProbabilityDistributionType - T,1
2448,Probes,5
2449,PROC gene,2
2450,Procedural approach,1
2451,Process,14
2452,Process of secretion,4
2453,Processing (action),1
2454,product,14
2455,production,11
2456,Profile (lab procedure),2
2457,Prognosis bad,1
2458,Program,1
2459,Progression,3
2460,Progressive,3
2461,Project,7
2462,Prokaryote,1
2463,Proliferating Cell Nuclear Antigen,4
2464,Proliferation,26
2465,Proliferation (morphologic abnormality),1
2466,Proline,1
2467,Proline-Rich Domain,1
2468,Prolonged,2
2469,Prominent,4
2470,promoter,16
2471,"Promoter Regions, Genetic",2
2472,Promotion (action),10
2473,PROP1 gene,2
2474,Prophase,2
2475,Proportion,2
2476,Proposal (document),1
2477,Prosencephalon,3
2478,Prostate,1
2479,Prostate carcinoma,1
2480,Prostatic epithelium,1
2481,pro-survival,1
2482,Protease Inhibitors,1
2483,proteasome complex disassembly,4
2484,Proteasome Pathway,2
2485,Protection,4
2486,Protein Acetylation,16
2487,Protein Binding,1
2488,Protein Binding Motif,1
2489,Protein Biosynthesis,5
2490,Protein complex,2
2491,"Protein Conformation, beta-Strand",2
2492,protein C-terminus binding,2
2493,protein desumoylation,1
2494,Protein Dimerization,1
2495,Protein Domain,11
2496,protein expression,120
2497,Protein Expression Analysis,1
2498,Protein Family,3
2499,protein folding,1
2500,Protein Fragment,1
2501,Protein Function,1
2502,Protein Import,2
2503,Protein Isoforms,41
2504,protein K63-linked ubiquitination,1
2505,Protein Kinases,9
2506,Protein level - finding,1
2507,Protein methylation,2
2508,protein methyltransferase activity,1
2509,protein monoubiquitination,2
2510,protein N-linked glycosylation,2
2511,protein oligomerization,2
2512,Protein Overexpression,41
2513,Protein p53,2
2514,Protein phosphatase,1
2515,protein protein interaction,5
2516,protein reconstitution,1
2517,protein self-association,3
2518,Protein Sequence Determination,1
2519,Protein Sorting Signals,1
2520,Protein Splicing,1
2521,Protein Stability,4
2522,"Protein Structure, Secondary",2
2523,Protein Subunits,28
2524,protein succinylation,2
2525,Protein translocation,16
2526,protein transport,3
2527,Protein Truncation Abnormality,3
2528,Protein Tyrosine Kinase,14
2529,Protein Tyrosine Phosphatase,1
2530,"Protein Tyrosine Phosphatase, Receptor Type B",9
2531,Protein-Arginine N-Methyltransferase,1
2532,Proteins,132
2533,Protein-Serine-Threonine Kinases,3
2534,Proteolysis,1
2535,Proteolytic Enzyme,2
2536,Proteomics,10
2537,Protocol Forms Template,1
2538,Protocols documentation,1
2539,Protomers,1
2540,Proto-Oncogene Protein c-met,2
2541,Proto-Oncogene Proteins c-akt,15
2542,Proto-Oncogene Proteins c-myc,10
2543,Proto-Oncogenes,3
2544,Protoplasm,11
2545,Providing presence (regime/therapy),9
2546,Proximal,3
2547,Proximal Interphalangeal Joint 3,1
2548,PRRT2 gene,1
2549,PSEN1 gene,3
2550,PSENEN wt Allele,4
2551,Psychologic Displacement,5
2552,PTEN activity,1
2553,PTEN gene,1
2554,PTEN Phosphohydrolase,4
2555,"PTEN protein, human",25
2556,PTEN wt Allele,2
2557,PTPN11 gene,1
2558,"PTPRB protein, human",3
2559,Publications,2
2560,Published Database,2
2561,Publishing,2
2562,Pulmonary Valve Insufficiency,1
2563,Punctate,2
2564,Purifying,4
2565,Purine Nucleotides,1
2566,Purines,3
2567,Purkinje Cells,3
2568,PURPOSE (pharmacologic preparation),1
2569,PWWP2A gene,9
2570,PWWP2B gene,1
2571,Pyramidal Cells,1
2572,Pyruvate Dehydrogenase Complex,1
2573,QDPR gene,3
2574,Qualitative mobility,2
2575,Quality,1
2576,quality control,1
2577,Quantitation,1
2578,Quantitative,4
2579,Quantitative Reverse Transcriptase PCR,1
2580,Quantity,1
2581,Question (inquiry),2
2582,rab GTP-Binding Proteins,3
2583,RAB13 gene,1
2584,RAB39B gene,1
2585,RAB5A gene,1
2586,Rabbits,5
2587,Racial Segregation,1
2588,RAD54L2 gene,6
2589,radial glia,1
2590,Radiolabeled,1
2591,Radiolucent,1
2592,RAI1 gene,20
2593,Raised intraocular pressure,1
2594,Rana <genus>,1
2595,Randomization,2
2596,Rapid,1
2597,RARB gene,1
2598,Ratio,1
2599,Rattus,9
2600,RBL2 wt Allele,1
2601,RBM14 gene,6
2602,React,1
2603,Reaction,4
2604,Reactivation,1
2605,Reactive,1
2606,reactive oxygen intermediate,1
2607,Reactive Oxygen Species,4
2608,Reagents,1
2609,receptor,53
2610,Receptor Activation Process,2
2611,receptor activator activity,1
2612,Receptor Protein-Tyrosine Kinases,35
2613,receptor recycling,1
2614,Receptor Signaling,1
2615,Receptor Tyrosine Kinase Gene,1
2616,"Receptor Tyrosine-Protein Kinase ErbB-4, human",66
2617,"Receptor, Serotonin, 5-HT2A",2
2618,"Receptor, Serotonin, 5-HT2C",7
2619,"Receptor, TIE-2",7
2620,"Receptors, Cell Surface",5
2621,"Receptors, Dihydropyridine",1
2622,"Receptors, Eph Family",2
2623,"Receptors, Nuclear",18
2624,"Receptors, Steroid",3
2625,Recognition (Psychology),3
2626,Recombinant DNA,1
2627,Recombinant Interleukin-1,1
2628,Recombinant Interleukin-4,7
2629,Recombinant melatonin,1
2630,Recombinant Proteins,1
2631,Recombinant Vascular Endothelial Growth Factor,1
2632,Recombinants,10
2633,recovery - adjustment,1
2634,Recycling,2
2635,Redistribution,1
2636,Reduced,72
2637,Reduction (chemical),22
2638,Redundancy,2
2639,Reeler,1
2640,Reelin Signaling Pathway PID,2
2641,Refractive surgery enhancement,5
2642,REG1A gene,1
2643,regenerated,1
2644,Regenerating muscle fiber,1
2645,Region of chromosome,1
2646,regional,13
2647,Regulation,42
2648,Regulation of biological process,1
2649,regulation of developmental process,1
2650,regulation of metabolism,1
2651,regulation of mitophagy,1
2652,Regulator,24
2653,Regulators (device),8
2654,Regulatory Pathway,1
2655,regulatory proteins,1
2656,"Regulatory Sequences, Nucleic Acid",1
2657,Regulatory T-Lymphocytes,5
2658,Relative ratio,1
2659,Relaxation,1
2660,Release - action (qualifier value),2
2661,release of sequestered calcium ion into cytoplasm,5
2662,Relevance,2
2663,RELN gene,5
2664,Renal function,1
2665,reorganization,2
2666,Reorientation,2
2667,Reparative closure,1
2668,Repeat,13
2669,Replicate Specimen,1
2670,Report (document),11
2671,Reporter (occupation),3
2672,Repositioning (procedure),1
2673,representational difference analysis,1
2674,"Repression, Psychology",2
2675,Reproductive function,1
2676,Reproductive process,1
2677,Reprogram,2
2678,Requirement,1
2679,Research Personnel,1
2680,research study,14
2681,Resident (physician),1
2682,Residue after Decontamination Medical Device Problem,4
2683,"Resistance, Natural",1
2684,Resolution,4
2685,Resources,2
2686,Respiratory Failure,1
2687,Response process,7
2688,ResponseLevel - modification,9
2689,Restricted,6
2690,Result,1
2691,Retarded,1
2692,Retention - dental,1
2693,Retina,4
2694,retina layer formation,1
2695,Retinal Bipolar Cells,1
2696,Retinal Cone,2
2697,Retinal Ganglion Cells,5
2698,Retinal Neurons,1
2699,Retinoblastoma,1
2700,"Retinoic Acid Receptor Alpha, human",1
2701,Retinoic Acid Receptor RXR-Alpha,1
2702,Retinoids,1
2703,Retrograde approach,3
2704,Rett Syndrome,1
2705,reuptake,1
2706,Revealed,1
2707,Reverse Transcriptase Polymerase Chain Reaction,13
2708,Reversible,1
2709,rho GTP-Binding Proteins,3
2710,rhoA GTP-Binding Protein,2
2711,Rhythm,1
2712,Ribbon synapse,1
2713,Ribosomal Protein S6 Kinase Beta-1,1
2714,Ribosomal RNA,2
2715,Ribosomal RNA Genes,2
2716,Right ventricular structure,1
2717,RIPK1 gene,1
2718,Risedronate,1
2719,Risk,5
2720,Risk Codes - Aggressive,1
2721,Risk Evaluation and Mitigation Strategies Requirement,6
2722,risk factors,1
2723,RNA,14
2724,RNA biosynthesis,1
2725,RNA destabilization,1
2726,RNA Interference,7
2727,RNA Polymerase I,1
2728,RNA Polymerase II,4
2729,RNA Processing,2
2730,RNA Splicing,12
2731,"RNA, Messenger",42
2732,"RNA, Small Interfering",5
2733,"RNA, Untranslated",1
2734,RNA-Binding Motifs,5
2735,RNA-Binding Proteins,2
2736,RNASE1 gene,9
2737,RNF2 gene,6
2738,Robust,3
2739,ROCK1 gene,6
2740,ROCK1 wt Allele,1
2741,ROCK2 gene,1
2742,Role Class - content,2
2743,Roof physical object,1
2744,Rostral,3
2745,Routine Signature,2
2746,RPL41 gene,3
2747,rRNA Promoter,4
2748,rRNA synthesis,1
2749,ruffle membrane,1
2750,Ryanodine Receptors,2
2751,S Phase,7
2752,Saccharomyces cerevisiae,4
2753,S-acyltransferase activity,1
2754,SAFB gene,4
2755,SAFB wt Allele,1
2756,Sample pool,3
2757,Sarcolemma,3
2758,Sarcoplasmic Reticulum,7
2759,Scaffold,2
2760,Scaffold protein,5
2761,Scattered,1
2762,scenario,1
2763,Schizophrenia,3
2764,Schizosaccharomyces,1
2765,Schizosaccharomyces pombe,1
2766,Scientific Study,54
2767,Sclerotome device,1
2768,SCRIB gene,3
2769,SCYL1 gene,1
2770,"SDHD protein, human",1
2771,Sebaceous Glands,1
2772,second (number),1
2773,Secondary Immunization,2
2774,Secondary Neoplasm,1
2775,Seizures,1
2776,selectin activity,2
2777,"SELP protein, human",4
2778,SEMA3A gene,1
2779,SEMA4C gene,5
2780,SEMA5A gene,20
2781,SEMA5B gene,2
2782,Semaphorins,9
2783,Seminiferous tubule structure,1
2784,SENP3 gene,1
2785,Sense of identity (observable entity),11
2786,Sense Organs,1
2787,Sensitive,4
2788,sensor (device),3
2789,Sepsis,1
2790,SEPT4 gene,7
2791,Sequence - TransmissionRelationshipTypeCode,40
2792,Sequence Analysis,5
2793,Sequence Data Type,1
2794,Sequence Similarity,2
2795,Sequential - Sequence/Results Flag,1
2796,Series - set of composite instances,2
2797,Serine,6
2798,Serotonin,10
2799,Serpin B9,1
2800,Serum,2
2801,"Serum Albumin, Bovine",1
2802,Serum amyloid A protein,1
2803,Serum Response Factor,3
2804,Service Request Relationship - Compound,1
2805,Service Request Relationship - Simultaneous,2
2806,Set (Psychology),2
2807,SET gene,1
2808,Set of polysomal ribosomes,1
2809,SETD5 gene,9
2810,Seventh,2
2811,Severe (severity modifier),17
2812,Severities,3
2813,Severity of illness,1
2814,Sf21 Cells,1
2815,SGCG gene,1
2816,SH2 Domain,6
2817,SH3 and Multiple Ankyrin Repeat Domains Protein 3,9
2818,SH3GL2 gene,1
2819,Sharing (Social Behavior),2
2820,SHB gene,1
2821,SHH gene,3
2822,SHISA6 gene,6
2823,SHISA7 gene,6
2824,Shock,1
2825,Short,3
2826,Short Hairpin RNA,2
2827,short-term,2
2828,Signal,5
2829,Signal Pathways,9
2830,Signal Peptides,2
2831,"Signal Processing, Computer-Assisted",1
2832,signal transducer activity,1
2833,Signal Transduction,14
2834,Signal Transduction Pathways,4
2835,Signaling Molecule,2
2836,Signaling Protein,2
2837,Significant,5
2838,Signs and Symptoms,4
2839,simian virus,1
2840,Similarity,5
2841,Simplex styrene-methylmethacrylate,1
2842,Simultaneous,4
2843,Single-pass plasma transmembrane protein,1
2844,Sirolimus,2
2845,SIRT1 gene,9
2846,SIRT5 gene,3
2847,Site,33
2848,Sixth,2
2849,size,11
2850,Skeletal bone,1
2851,skeletal muscle cell differentiation,1
2852,Skeletal muscle structure,9
2853,Skeletal Myocytes,3
2854,Skin,3
2855,SLC22A18 wt Allele,1
2856,SLC30A9 gene,5
2857,SLC3A2 gene,3
2858,SLC4A1 wt Allele,1
2859,SLC6A4 wt Allele,4
2860,"SLC8A1 protein, human",2
2861,"Sleep Disorders, Circadian Rhythm",1
2862,Slow,3
2863,SLTM gene,6
2864,Small brain,1
2865,Small cerebral cortex,1
2866,SMARCA4 wt Allele,1
2867,SMCR8 gene,1
2868,Smith-Magenis syndrome,12
2869,SMN Complex Proteins,2
2870,Smooth muscle (tissue),1
2871,Social Behavior,1
2872,Social engagement,2
2873,Social Interaction,71
2874,Social Networks,5
2875,social resistance,4
2876,Social Role,1
2877,Sodium Chloride,1
2878,soluble,5
2879,Solutions,1
2880,Somatic,1
2881,Somatostatin Receptor,1
2882,somatostatin receptor 1,2
2883,somatostatin receptor 2,6
2884,somite development,1
2885,Somites,8
2886,somitogenesis,1
2887,Sonic Hedgehog Pathway,1
2888,Sorting - Cell Movement,1
2889,sorting endosome,2
2890,Source,1
2891,Southern Blot result,2
2892,SOX18 gene,6
2893,SOX2 gene,1
2894,SOX3 gene,3
2895,SP1 wt Allele,1
2896,SPARC gene,1
2897,"SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE",1
2898,Special,5
2899,Species,3
2900,Specification,1
2901,Specificity,10
2902,Specimen Source Codes - Respiratory,1
2903,Specimen Source Codes - Spermatozoa,2
2904,Specimen Source Codes - Tissue lung,1
2905,Specimen Type - Fibroblasts,6
2906,Specimen Type - Lymphocytes,1
2907,Spectrum,2
2908,sperm chromatin condensation,1
2909,Spermatid,2
2910,Spermatocytes,2
2911,Spermatogenesis,4
2912,Spermatogonia,3
2913,Spermatozoa Cell Count,7
2914,Spermiogenesis,2
2915,Spinal Cord,2
2916,Spindle Poles,1
2917,Spleen,4
2918,Splice Acceptor Site,1
2919,Sporadic (qualifier value),1
2920,Spreading (qualifier value),1
2921,SPSB1 gene,2
2922,SPSB2 gene,2
2923,SPSB3 gene,1
2924,SPSB4 gene,2
2925,Squamous cell carcinoma,1
2926,SR1001,4
2927,SRC gene,3
2928,src-Family Kinases,1
2929,SRF gene,2
2930,SRSF3 gene,1
2931,SSRP1 gene,2
2932,SSTR2 gene,2
2933,ST7 wt Allele,4
2934,Stabilization,4
2935,Stabilized (qualifier value),2
2936,Stable status,1
2937,Stage,5
2938,Starvation,1
2939,Stat (do immediately),1
2940,STAT protein,1
2941,"STAT5A protein, human",19
2942,STAT5A wt Allele,8
2943,Statement,1
2944,statistical cluster,5
2945,Statistical Frequency,1
2946,Statistical sensitivity,7
2947,status - In progress,1
2948,Stem Cell Self-Renewal,3
2949,Stem cells,7
2950,Stem of Organ,1
2951,steroid hormone receptor,1
2952,steroid receptor coactivator AIB1,2
2953,Steroids,3
2954,Stimulant,1
2955,Stimulation (motivation),8
2956,Stimulation of Cell Proliferation,3
2957,stimulation of growth,1
2958,Stimulation procedure,24
2959,Stimulus,2
2960,Stoichiometry,1
2961,Stomach,1
2962,Stool seat,1
2963,Streams,1
2964,Stress,3
2965,Stress Fibers,1
2966,Structural protein,1
2967,structure,24
2968,Structure of allantois,1
2969,Structure of amnion,4
2970,Structure of corpus luteum of ovary,1
2971,Structure of cortex of lens,1
2972,Structure of dentate gyrus,2
2973,Structure of interstitial cell of Leydig,1
2974,Structure of myotome,2
2975,Structure of olfactory bulb,6
2976,Structure of renal segment,1
2977,Study Element,4
2978,study of epigenetics,1
2979,Subcellular Fractions,4
2980,Subcutaneous Fat,1
2981,Subgroup,4
2982,Subject -direct target,2
2983,subrhabdomeral cisterna,1
2984,Substitution - change,4
2985,Substrate,8
2986,Subtraction process,2
2987,Subtractive Hybridization Techniques,1
2988,Subtype (attribute),10
2989,Subventricular Zone,1
2990,Sufficient,1
2991,Sulfhydryl Compounds,4
2992,sulforafan,2
2993,SUMO2 gene,1
2994,SUMO3 gene,1
2995,Sumoylation,5
2996,Superficial,1
2997,Suppressed,16
2998,Suppressor of Cytokine Signaling Proteins,1
2999,Surface,7
3000,Surgical construction,2
3001,Surgical Replantation,1
3002,Surveys,1
3003,Survival Rate,1
3004,survive,1
3005,Survivors,1
3006,Susceptibility (property) (qualifier value),4
3007,Sustain,1
3008,Sustained,2
3009,SWI/SNF complex,1
3010,Swiss 3T3 Cells,1
3011,Switch Device Component,2
3012,Symptomatic,1
3013,synapse maturation,1
3014,Synapses,14
3015,Synaptic cleft,1
3016,Synaptic connectivity,1
3017,Synaptic Transmission,6
3018,synaptic vesicle localization,1
3019,Synaptic Vesicles,3
3020,synaptogenesis,2
3021,Synaptosomes,4
3022,Synchronous,2
3023,SYNRG gene,1
3024,Synthesis,4
3025,Systemic arterial pressure,1
3026,T cell apoptotic process,1
3027,Table Frame -box,1
3028,Table Rules - groups,1
3029,Tail,2
3030,Talin,1
3031,Tandem Mass Spectrometry,2
3032,TARDBP gene,1
3033,Target,10
3034,Target Cell Count,1
3035,Target Lesion Identification,22
3036,TATA Box,1
3037,TATA-Box Binding Protein,2
3038,Tau - Statistical Technique,1
3039,TBATA gene,5
3040,TBC1D21 gene,6
3041,T-Cell Activation,1
3042,T-Cell Immunoreceptor with Ig and ITIM Domains,1
3043,T-Cell Proliferation,1
3044,T-Cell Receptor,1
3045,TCF12 gene,4
3046,TCF3 gene,1
3047,TCF4 gene,4
3048,TCF4 wt Allele,9
3049,TCF7L2 gene,10
3050,Techniques,3
3051,Technology,3
3052,TEK gene,69
3053,Telephone Extension Number,1
3054,Temporal - Regional site descriptor,3
3055,teratologic,2
3056,Teratoma,1
3057,Teratozoospermia,1
3058,Term Source,1
3059,terminal differentiation,1
3060,Terminally Ill,1
3061,termination - ActReason,1
3062,"Terminator Regions, Genetic",1
3063,Test Method,3
3064,Test Result,43
3065,Testicular Tissue,2
3066,Testiculo-,4
3067,Testis,11
3068,Testis-Specific Gene 10 Protein,1
3069,Tests (qualifier value),4
3070,Tethered,1
3071,Tetrodotoxin,1
3072,TEX101 gene,1
3073,TFAP4 gene,1
3074,"TFF1 protein, human",1
3075,TGFB1I1 gene,1
3076,Thalamic structure,2
3077,Therapeutic - Location Service Code,6
3078,Therapeutic procedure,3
3079,thiol-dependent ubiquitin-specific protease activity,5
3080,Three-dimensional,3
3081,Threonine measurement,1
3082,Threshold,1
3083,Thrombosis of blood vessel,2
3084,Thymine DNA Glycosylase,1
3085,thymocyte,2
3086,Thymus Gland,1
3087,THYROID HORMONE PLASMA MEMBRANE TRANSPORT DEFECT,4
3088,Thyroid Hormone Receptor Alpha-1,1
3089,Tibial Arteries,1
3090,TIE1 gene,3
3091,Time,1
3092,Timing,1
3093,TIMM8A gene,1
3094,Tip,1
3095,Tissue Adhesions,2
3096,Tissue Donors,1
3097,Tissue fiber,2
3098,tissue homeostasis,2
3099,Tissue membrane,1
3100,tissue regeneration,2
3101,Tissue Specificity,1
3102,Tissue-Specific Splicing,7
3103,TLE4 wt Allele,1
3104,T-Lymphocyte,4
3105,"TM4SF1 protein, human",2
3106,"TNFSF11 protein, human",1
3107,TNIK gene,6
3108,TNS1 gene,1
3109,Toll-like receptors,1
3110,TOMM20 gene,2
3111,Tongue,1
3112,Topical Dosage Form,1
3113,TOR signaling,2
3114,tortuous aorta,1
3115,Total Peripheral Resistance,1
3116,Toxic,1
3117,Toxicity aspects,1
3118,TP53 gene,17
3119,"TP53INP1 protein, human",2
3120,TPM3 wt Allele,2
3121,trabecula formation,1
3122,Trabecular meshwork structure,1
3123,Tract,2
3124,Traffic,1
3125,trafficking,4
3126,Transaction counts and value totals - day,11
3127,"Trans-Activation, Genetic",8
3128,Trans-Activators,2
3129,Transcript,35
3130,Transcription Activator-Like Effectors,1
3131,Transcription Coactivator,10
3132,Transcription Elongation,2
3133,TRANSCRIPTION FACTOR,30
3134,Transcription Factor 3,1
3135,Transcription Factor AP-2 Alpha,3
3136,transcription factor S-II,1
3137,Transcription Factor TFIIB,1
3138,Transcription Factor TFIID,2
3139,"Transcription Factors, General",2
3140,transcription from mitochondrial promoter,1
3141,Transcription Initiation,1
3142,Transcription Repressor/Corepressor,2
3143,"Transcription, Genetic",54
3144,Transcriptional Activation,11
3145,Transcriptional Activation Domain,1
3146,Transcriptional Regulation,9
3147,Transcriptional Repression,3
3148,"Transcriptional Repressor Protein YY1, human",1
3149,Transcriptome,1
3150,Transcytotic Pathways,1
3151,Transducers,3
3152,Transfection,4
3153,Transferrin measurement,2
3154,Transforming Growth Factor Beta 2,1
3155,Transforming Growth Factor Beta-1-Induced Transcript 1 Protein,4
3156,transforming growth factor beta3,1
3157,Transforming Growth Factors,1
3158,Transgenes,2
3159,trans-Golgi Network,4
3160,Transition (action),9
3161,Transitory,1
3162,Transjugular intrahepatic portosystemic shunt procedure,3
3163,Translating,1
3164,Translation Initiation,1
3165,Translational Repression,2
3166,Transmembrane Domain,2
3167,transmission process,1
3168,Transmitted by,1
3169,Transplanted tissue,1
3170,Transport Device Component,4
3171,trans-synaptic signaling by trans-synaptic complex,1
3172,Traumatic injury,1
3173,Treating,9
3174,Treatment Study,17
3175,Tretinoin,3
3176,Trial Inclusion and Exclusion Criteria Submission Domain,8
3177,Trial Phase 3B,1
3178,Trial Screening,9
3179,trichostatin A,2
3180,Triggered by,4
3181,"TRIM25 protein, human",1
3182,Trisomy,3
3183,Triton X-100,1
3184,trophoblast,1
3185,Trophoblast cell,1
3186,"tropomyosin-related kinase-B, human",3
3187,Troponin I,3
3188,TRPM1 gene,1
3189,"TRPM3 protein, human",1
3190,Truncated BID,2
3191,Trunk structure,1
3192,TSC2 gene,2
3193,Tuberculosis,2
3194,Tuberous Sclerosis,4
3195,TUBEROUS SCLEROSIS 1 (disorder),15
3196,TUBEROUS SCLEROSIS 2 (disorder),8
3197,tuberous sclerosis complex 2 protein,10
3198,Tubulin,3
3199,tubulogenesis,1
3200,Tumor Angiogenesis,1
3201,Tumor Cell Invasion,2
3202,"Tumor cells, malignant",6
3203,tumor growth,1
3204,Tumor Necrosis Factor-alpha,10
3205,Tumor Suppressor Genes,11
3206,Tumor tissue sample,1
3207,Turnover technique,2
3208,Two-Hybrid System Techniques,1
3209,Type 2,1
3210,Type of bridge device,1
3211,Type of restoration,1
3212,tyrosine binding,1
3213,Tyrosine Kinase Domain,1
3214,Tyrosine measurement,24
3215,tyrosine receptor,1
3216,"Tyrosine-Protein Kinase ABL1, human",1
3217,Ubiquitin,2
3218,ubiquitin activity,3
3219,Ubiquitin Ligase Gene,3
3220,Ubiquitinated Proteins,1
3221,Ubiquitination,20
3222,ubiquitin-like protein conjugating enzyme activity,2
3223,ubiquitin-protein ligase,9
3224,UHRF1 gene,3
3225,Ultrastructure,3
3226,undefined,1
3227,Undetectable,1
3228,Undifferentiated,3
3229,Unidentified - modifier,2
3230,Unilateral,1
3231,Unique,8
3232,United Arab Emirates,1
3233,United States,2
3234,Units Of Measure - Gilbert,1
3235,Unrelated (finding),1
3236,Untranslated Regions,1
3237,Unusual,2
3238,Upper,1
3239,Up-Regulation (Physiology),7
3240,Upstream,5
3241,Uroporphyrinogen III Synthetase,1
3242,Ursidae Family,1
3243,Usage,1
3244,USP1 gene,4
3245,USP7 gene,21
3246,Usual,1
3247,Uterine Tachysystole,1
3248,Utility (animal life circumstance),2
3249,utilization qualifier,1
3250,UTS2R gene,1
3251,Vaccinia virus,1
3252,Vacuolar Protein Sorting,1
3253,Value Below Reference Range,11
3254,Values,1
3255,Variable (uniformity),1
3256,Variable expressivity,1
3257,Variant,22
3258,Vascular anomaly,1
3259,Vascular constriction (function),2
3260,vascular cord development,6
3261,Vascular Endothelial Cells,3
3262,Vascular Endothelial Growth Factor A,1
3263,Vascular Endothelial Growth Factor Receptor-2,1
3264,Vascular plexus,2
3265,Vascular Remodeling,1
3266,Vascular System,5
3267,Vascularization,1
3268,Vasculature,4
3269,vasculogenesis,4
3270,Vasoactive Intestinal Peptide,1
3271,VAX1 gene,1
3272,VAX2 gene,1
3273,"VCL protein, human",1
3274,Vegetable marrow,1
3275,Venous system,1
3276,Version,1
3277,Vertebral column,2
3278,Vertebrates,15
3279,Vesicle (morphologic abnormality),6
3280,vesicle coat,1
3281,vesicle-mediated transport,1
3282,Viable,1
3283,View,1
3284,Viral,1
3285,Viral Genome,1
3286,Virus Diseases,1
3287,Virus Physiological Phenomena,1
3288,virus tail structure,1
3289,Vision,2
3290,Visual learning,2
3291,Visual Suppression,8
3292,Vitamin D3 Receptor,1
3293,VLDLR gene,1
3294,voltage,2
3295,von Willebrand factor,5
3296,VPS45 gene,1
3297,WASF1 gene,4
3298,WASF2 wt Allele,2
3299,WASH1 gene,11
3300,WASL gene,1
3301,WD40 Repeats,2
3302,WDR41 gene,1
3303,Weakness,1
3304,Weight Gain,1
3305,Well Differentiated,5
3306,West (direction),1
3307,Western Blot,3
3308,WFDC5 gene,1
3309,What subject filter - Status,1
3310,White Adipose Tissue,2
3311,Whole Transcriptome Sequencing,1
3312,Wild Type,3
3313,Williams Syndrome,1
3314,Wiskott-Aldrich Syndrome Protein,4
3315,With configuration,4
3316,With staging,1
3317,Withdrawal (dysfunction),2
3318,Wnt Signaling Pathway,4
3319,Wnt1 Protein,1
3320,Wound Healing,4
3321,X^o^rX^o^r blood group phenotype,21
3322,xanthine,1
3323,Xenopus oocyte,1
3324,Xenopus subgenus,2
3325,XML Bound,1
3326,Y 27632,1
3327,year,3
3328,Yeast Cell Measurement,3
3329,Yeast Two-Hybrid System Techniques,15
3330,Yeasts,7
3331,yolk,4
3332,Young,2
3333,YWHAE gene,2
3334,ZBTB8OS gene,1
3335,ZDHHC5 gene,5
3336,Zebrafish,3
3337,Zinc,1
3338,Zinc Fingers,1
3339,ZNF451 gene,10
